{
  "cache_date": "2025-03-14T02:49:43.329949",
  "data": [
    {
      "created": "2025-03-11T16:52:47.183910+00:00",
      "modified": "2025-03-11T16:52:47.727301+00:00",
      "id": 13821321,
      "conceptrecid": "13821320",
      "doi": "10.5281/zenodo.13821321",
      "conceptdoi": "10.5281/zenodo.13821320",
      "doi_url": "https://doi.org/10.5281/zenodo.13821321",
      "metadata": {
        "title": "SELPHI2.0: Data-driven extraction of human kinase-substrate relationships from omics datasets",
        "doi": "10.5281/zenodo.13821321",
        "publication_date": "2024-09-20",
        "description": "<p>In this study, we have created a machine learning-based model to derive a probabilistic kinase-substrate network from omics datasets.&nbsp; Our methodology displays improved performance compared to other state-of-the-art kinase-substrate prediction methods, and provides predictions for more kinases. Importantly, it better captures new experimentally-identified kinase-substrate relationships. It can therefore allow the improved prioritisation of kinase-substrate pairs for illuminating the dark human cell signalling space. Our model is integrated into a web server, SELPHI2.0, to allow unbiased analysis of phosphoproteomics data, facilitating the design of downstream experiments to uncover mechanisms of signal transduction across conditions and cellular contexts.</p>\n<p>The SELPHI2.0 web server is freely available under: <a href=\"https://selphi2.com\">https://selphi2.com</a>&nbsp; and all code for reproducing this project can be found at <a href=\"https://gitlab.ebi.ac.uk/petsalakilab/selphi_2.0\">https://gitlab.ebi.ac.uk/petsalakilab/selphi_2.0</a> and <a href=\"https://github.com/alussana/selphi2.0-pssms\">https://github.com/alussana/selphi2.0-pssms</a>. A Docker image of the web server can be found at: <a href=\"https://gitlab.ebi.ac.uk/petsalakilab/selphi_2\">https://gitlab.ebi.ac.uk/petsalakilab/selphi_2</a>.</p>",
        "access_right": "open",
        "creators": [
          {
            "name": "Maier, Benjamin Dominik",
            "affiliation": "European Bioinformatics Institute",
            "orcid": "0000-0001-8442-0536"
          },
          {
            "name": "Petursson, Borgthor",
            "affiliation": "European Bioinformatics Institute",
            "orcid": "0000-0002-6784-6882"
          },
          {
            "name": "Lussana, Alessandro",
            "affiliation": "European Bioinformatics Institute",
            "orcid": "0000-0002-4733-0934"
          },
          {
            "name": "Petsalaki, Evangelia",
            "affiliation": "European Bioinformatics Institute",
            "orcid": "0000-0002-8294-2995"
          }
        ],
        "custom": {
          "code:codeRepository": "https://gitlab.ebi.ac.uk/petsalakilab/selphi_2.0",
          "code:programmingLanguage": [
            {
              "id": "r",
              "title": {
                "en": "R"
              }
            },
            {
              "id": "python",
              "title": {
                "en": "Python"
              }
            },
            {
              "id": "nextflow",
              "title": {
                "en": "Nextflow"
              }
            },
            {
              "id": "shell",
              "title": {
                "en": "Shell"
              }
            }
          ]
        },
        "resource_type": {
          "title": "Dataset",
          "type": "dataset"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "13821320"
              }
            }
          ]
        }
      },
      "title": "SELPHI2.0: Data-driven extraction of human kinase-substrate relationships from omics datasets",
      "links": {
        "self": "https://zenodo.org/api/records/13821321",
        "self_html": "https://zenodo.org/records/13821321",
        "doi": "https://doi.org/10.5281/zenodo.13821321",
        "self_doi": "https://doi.org/10.5281/zenodo.13821321",
        "self_doi_html": "https://zenodo.org/doi/10.5281/zenodo.13821321",
        "parent": "https://zenodo.org/api/records/13821320",
        "parent_html": "https://zenodo.org/records/13821320",
        "parent_doi": "https://doi.org/10.5281/zenodo.13821320",
        "parent_doi_html": "https://zenodo.org/doi/10.5281/zenodo.13821320",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:13821321/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:13821321/sequence/default",
        "files": "https://zenodo.org/api/records/13821321/files",
        "media_files": "https://zenodo.org/api/records/13821321/media-files",
        "archive": "https://zenodo.org/api/records/13821321/files-archive",
        "archive_media": "https://zenodo.org/api/records/13821321/media-files-archive",
        "latest": "https://zenodo.org/api/records/13821321/versions/latest",
        "latest_html": "https://zenodo.org/records/13821321/latest",
        "versions": "https://zenodo.org/api/records/13821321/versions",
        "draft": "https://zenodo.org/api/records/13821321/draft",
        "reserve_doi": "https://zenodo.org/api/records/13821321/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/13821321/access/links",
        "access_grants": "https://zenodo.org/api/records/13821321/access/grants",
        "access_users": "https://zenodo.org/api/records/13821321/access/users",
        "access_request": "https://zenodo.org/api/records/13821321/access/request",
        "access": "https://zenodo.org/api/records/13821321/access",
        "communities": "https://zenodo.org/api/records/13821321/communities",
        "communities-suggestions": "https://zenodo.org/api/records/13821321/communities-suggestions",
        "requests": "https://zenodo.org/api/records/13821321/requests"
      },
      "updated": "2025-03-11T16:52:47.727301+00:00",
      "recid": "13821321",
      "revision": 3,
      "files": [
        {
          "id": "f1552ef7-0ba6-4f5a-bff5-596b8225de51",
          "key": "prediction_matrix.csv",
          "size": 8339552421,
          "checksum": "md5:03ceb8363f6cd0ba3d5f9ab336df6675",
          "links": {
            "self": "https://zenodo.org/api/records/13821321/files/prediction_matrix.csv/content"
          }
        },
        {
          "id": "8d0c0197-d24e-43c6-ab2a-e9c7367e4f3d",
          "key": "prediction_matrix_overlap.csv",
          "size": 8715,
          "checksum": "md5:bff0295e6f53190c6f215852fa436bfb",
          "links": {
            "self": "https://zenodo.org/api/records/13821321/files/prediction_matrix_overlap.csv/content"
          }
        },
        {
          "id": "1eb94648-48e3-4517-88df-e3659dd04802",
          "key": "prediction_matrix_high_conf_curated.csv",
          "size": 87367852,
          "checksum": "md5:c36302795bb7f943f6ab7ab49ed1cad2",
          "links": {
            "self": "https://zenodo.org/api/records/13821321/files/prediction_matrix_high_conf_curated.csv/content"
          }
        },
        {
          "id": "6efdd228-3b99-45f2-81f1-d1cd5a86ff61",
          "key": "k_p_tyr_pssm_scores.tsv",
          "size": 3859712208,
          "checksum": "md5:8f64534736b14774aee63d3460d2587c",
          "links": {
            "self": "https://zenodo.org/api/records/13821321/files/k_p_tyr_pssm_scores.tsv/content"
          }
        },
        {
          "id": "24a62b1a-39aa-47d9-adb0-8c88f9ee76ab",
          "key": "k_p_ser_thr_pssm_scores.tsv",
          "size": 4106404569,
          "checksum": "md5:34145cc521278754aa6c0a83fa135ac0",
          "links": {
            "self": "https://zenodo.org/api/records/13821321/files/k_p_ser_thr_pssm_scores.tsv/content"
          }
        },
        {
          "id": "c8d5f5c5-b32e-4760-ae75-b3963463a400",
          "key": "kinase-kinase-rels-kinome_kin_20240910.tsv",
          "size": 61507,
          "checksum": "md5:f832fef7c4d033c1a4a0920fb5ee5416",
          "links": {
            "self": "https://zenodo.org/api/records/13821321/files/kinase-kinase-rels-kinome_kin_20240910.tsv/content"
          }
        },
        {
          "id": "2ed68465-561c-4359-b5b3-1b5f8fd70e47",
          "key": "kinase-kinase-rels-kinome_sub_20240910.tsv",
          "size": 114705,
          "checksum": "md5:473154148b155e0a1f6c9515af9d6dd1",
          "links": {
            "self": "https://zenodo.org/api/records/13821321/files/kinase-kinase-rels-kinome_sub_20240910.tsv/content"
          }
        },
        {
          "id": "01099648-4a1b-4450-b9c8-ce9f5eac64c6",
          "key": "feature_table.tsv",
          "size": 10749489731,
          "checksum": "md5:971fa99e2786b669b4ca737205a262d4",
          "links": {
            "self": "https://zenodo.org/api/records/13821321/files/feature_table.tsv/content"
          }
        },
        {
          "id": "eb197929-6957-423d-b072-62a20402ead0",
          "key": "kinase-citations-2_kin_20240910.tsv",
          "size": 55115,
          "checksum": "md5:646399fd1b8a98a5258f35f51b2da197",
          "links": {
            "self": "https://zenodo.org/api/records/13821321/files/kinase-citations-2_kin_20240910.tsv/content"
          }
        },
        {
          "id": "fb6322b3-2a78-4ebb-bdda-81db7296dcc2",
          "key": "positive-set-20240910.tsv",
          "size": 224251,
          "checksum": "md5:b5f74ab1770417609566dc4063937137",
          "links": {
            "self": "https://zenodo.org/api/records/13821321/files/positive-set-20240910.tsv/content"
          }
        },
        {
          "id": "ae83349a-1fbc-495a-841d-ea1c580a41c3",
          "key": "kinase-citations-2_sub_20240910.tsv",
          "size": 985217,
          "checksum": "md5:7bde285384b3cb9c33aaec0f0dc28708",
          "links": {
            "self": "https://zenodo.org/api/records/13821321/files/kinase-citations-2_sub_20240910.tsv/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "1192108"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 35,
        "unique_downloads": 33,
        "views": 3,
        "unique_views": 3,
        "version_downloads": 35,
        "version_unique_downloads": 33,
        "version_unique_views": 3,
        "version_views": 3
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-03-11T09:37:39.270331+00:00",
      "modified": "2025-03-11T09:37:39.590777+00:00",
      "id": 15004535,
      "conceptrecid": "15004534",
      "doi": "10.5281/zenodo.15004535",
      "conceptdoi": "10.5281/zenodo.15004534",
      "doi_url": "https://doi.org/10.5281/zenodo.15004535",
      "metadata": {
        "title": "Global panorama of phage-host interactions driving antimicrobial resistance gene transfer in livestock manure anaerobic digestion",
        "doi": "10.5281/zenodo.15004535",
        "publication_date": "2025-03-11",
        "description": "<p><span>Antimicrobial resistance poses a global threat to human health, with livestock manure being a major reservoir of antimicrobial resistance genes (ARGs). Here, we present a global analysis of 205 metagenomic and 36 meta-transcriptomic datasets from anaerobic digestion (AD) systems treating livestock manure. We reveal that pig manure AD harbors the highest ARG abundance (0.709 ARGs/16S rRNA genes), and the expression of ARGs was found to be at a lower level</span><span> </span><span>(abundance/transcription &lt; 0.24). <span>A <a name=\"_Hlk191041336\"></a>global <a name=\"_Hlk192492942\"></a><span>viral database of livestock manure AD (GVD_LMAD)</span><span> comprising 59,316 non-redundant DNA viral operational taxonomic units (vOTUs) and 727 non-redundant RNA vOTUs </span>was established. </span>While lytic phages predominantly reduce ARGs by lysing antimicrobial resistant bacteria, the <span>reproduction and transduction role of viral communities on the transfer of ARGs were also elucidated</span>. We further built <a name=\"_Hlk192492977\"></a>the global antiviral defense systems (ADS) catalogue of livestock manure AD (GADSC_LMAD), encompassing 33,996 ADS-related genes, which not only protect antimicrobial resistant bacteria from phage predation but also inhibit the transfer of ARGs. Our findings provide actionable insights for enhancing the reduction of ARGs in livestock manure AD, and underscore the need to integrate phage ecology into AMR mitigation strategies.</span></p>",
        "access_right": "open",
        "creators": [
          {
            "name": "Tang, Qihe",
            "affiliation": null
          },
          {
            "name": "Zhang, Junya",
            "affiliation": "Research Center for Eco-Environmental Sciences",
            "orcid": "0000-0002-7959-2701"
          }
        ],
        "keywords": [
          "Viral community",
          "Anaerobic digestion",
          "Livestock manure",
          "Antimicrobial resistance genes",
          "Antiviral defense system"
        ],
        "version": "V1.0",
        "language": "eng",
        "resource_type": {
          "title": "Dataset",
          "type": "dataset"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "15004534"
              }
            }
          ]
        }
      },
      "title": "Global panorama of phage-host interactions driving antimicrobial resistance gene transfer in livestock manure anaerobic digestion",
      "links": {
        "self": "https://zenodo.org/api/records/15004535",
        "self_html": "https://zenodo.org/records/15004535",
        "doi": "https://doi.org/10.5281/zenodo.15004535",
        "self_doi": "https://doi.org/10.5281/zenodo.15004535",
        "self_doi_html": "https://zenodo.org/doi/10.5281/zenodo.15004535",
        "parent": "https://zenodo.org/api/records/15004534",
        "parent_html": "https://zenodo.org/records/15004534",
        "parent_doi": "https://doi.org/10.5281/zenodo.15004534",
        "parent_doi_html": "https://zenodo.org/doi/10.5281/zenodo.15004534",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:15004535/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:15004535/sequence/default",
        "files": "https://zenodo.org/api/records/15004535/files",
        "media_files": "https://zenodo.org/api/records/15004535/media-files",
        "archive": "https://zenodo.org/api/records/15004535/files-archive",
        "archive_media": "https://zenodo.org/api/records/15004535/media-files-archive",
        "latest": "https://zenodo.org/api/records/15004535/versions/latest",
        "latest_html": "https://zenodo.org/records/15004535/latest",
        "versions": "https://zenodo.org/api/records/15004535/versions",
        "draft": "https://zenodo.org/api/records/15004535/draft",
        "reserve_doi": "https://zenodo.org/api/records/15004535/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/15004535/access/links",
        "access_grants": "https://zenodo.org/api/records/15004535/access/grants",
        "access_users": "https://zenodo.org/api/records/15004535/access/users",
        "access_request": "https://zenodo.org/api/records/15004535/access/request",
        "access": "https://zenodo.org/api/records/15004535/access",
        "communities": "https://zenodo.org/api/records/15004535/communities",
        "communities-suggestions": "https://zenodo.org/api/records/15004535/communities-suggestions",
        "requests": "https://zenodo.org/api/records/15004535/requests"
      },
      "updated": "2025-03-11T09:37:39.590777+00:00",
      "recid": "15004535",
      "revision": 4,
      "files": [
        {
          "id": "2225951c-f98f-4b96-9b34-4bfd5c1f817b",
          "key": "06_ GADS_LMAD_Spacers_MAGs.xlsx",
          "size": 979808,
          "checksum": "md5:b2c24117acdb13e20f20acc2dd946868",
          "links": {
            "self": "https://zenodo.org/api/records/15004535/files/06_ GADS_LMAD_Spacers_MAGs.xlsx/content"
          }
        },
        {
          "id": "2d051c11-4d78-4064-b494-3204502aa9a1",
          "key": "01_GVD_LMAD_DNA_vOTUs.fasta",
          "size": 702874751,
          "checksum": "md5:e8b63331d2b5991c3187ca1b99c86f55",
          "links": {
            "self": "https://zenodo.org/api/records/15004535/files/01_GVD_LMAD_DNA_vOTUs.fasta/content"
          }
        },
        {
          "id": "c5d8f157-f504-4fa2-924b-b25af5a290b7",
          "key": "02_GVD_LMAD_RNA_vOTUs.fasta",
          "size": 1900709,
          "checksum": "md5:9c1c6518daa81e19d8b01520959ac913",
          "links": {
            "self": "https://zenodo.org/api/records/15004535/files/02_GVD_LMAD_RNA_vOTUs.fasta/content"
          }
        },
        {
          "id": "649f28d4-a708-4d43-8f26-3b7bf4c7dd8d",
          "key": "04_GADS_LMAD_defense_gene.fna",
          "size": 42254463,
          "checksum": "md5:81bdcb480a03b15aab58df82accb1980",
          "links": {
            "self": "https://zenodo.org/api/records/15004535/files/04_GADS_LMAD_defense_gene.fna/content"
          }
        },
        {
          "id": "e9920bbd-ed2a-4dec-a46f-a975349bfbe9",
          "key": "05_GADS_LMAD.xlsx",
          "size": 16541100,
          "checksum": "md5:7cf092121ef59b62eac22961078db9fa",
          "links": {
            "self": "https://zenodo.org/api/records/15004535/files/05_GADS_LMAD.xlsx/content"
          }
        },
        {
          "id": "d7ad7b30-0cfc-442d-bd80-db9e7c3af443",
          "key": "03_Global_LMAD_MAGs.zip",
          "size": 1800424659,
          "checksum": "md5:f02f25b8ce308f7fd9165cd2971eaa93",
          "links": {
            "self": "https://zenodo.org/api/records/15004535/files/03_Global_LMAD_MAGs.zip/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "1280333"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 16,
        "unique_downloads": 16,
        "views": 11,
        "unique_views": 9,
        "version_downloads": 16,
        "version_unique_downloads": 16,
        "version_unique_views": 9,
        "version_views": 11
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-03-07T07:00:03.951135+00:00",
      "modified": "2025-03-07T07:00:04.221290+00:00",
      "id": 14986745,
      "conceptrecid": "14986744",
      "doi": "10.11591/ijaas.v14.i1.pp276-281",
      "doi_url": "https://doi.org/10.11591/ijaas.v14.i1.pp276-281",
      "metadata": {
        "title": "Binary relaxor piezoceramic Pb (Mg1/3Nb2/3) O3-PbTiO3 for energy harvesting",
        "doi": "10.11591/ijaas.v14.i1.pp276-281",
        "publication_date": "2025-03-01",
        "description": "<p>Perovskite relaxor-PT piezoelectrics are suitable materials for energy harvesting. Relaxor-PT crystals have electromechanical properties that can replace lead zirconate titanate (PZT). However, the growth of these relaxor PT crystals is tedious and expensive. The important parameter for energy harvesting is the transduction rate (\ud835\udc51 &times; \ud835\udc54) where \ud835\udc51 represents the piezoelectric coefficient and \ud835\udc54 represents the piezoelectric voltage constant. There is always a challenge to obtain a high (\ud835\udc51 &times; \ud835\udc54) value. Lead magnesium niobate Pb (Mg1/3Nb2/3) O3-lead titanate PbTiO3 (PMN-PT) is a binary relaxor-PT ceramic and the morphotropic phase boundary (MPB) of (1-x) PMN-xPT ceramics occur around x=0.29-0.40 which is not exactly defined. So here we have synthesized 0.71PMN-0.29PT, 0.68PMN-0.32PT, and 0.65PMN-0.35PT compositions by two-step sintering solid-state method. The x-ray diffraction (XRD) patterns of the PMN-PT ceramics exhibit a characteristic perovskite structure and also show that PMN-PT ceramics fall within the region of MPB. Out of the three compositions, the 0.71PMN 0.29PT ceramics show a higher transduction rate (\ud835\udc51 &times; \ud835\udc54). So, this piezoelectric ceramic has the potential to replace costly piezoelectric single crystals in the creation of affordable, high-frequency energy harvesting devices.</p>",
        "access_right": "open",
        "creators": [
          {
            "name": "Bomkesh, Bhoi",
            "affiliation": "Gangadhar Meher University"
          },
          {
            "name": "Pranati, Purohit",
            "affiliation": "Gangadhar Meher University"
          }
        ],
        "keywords": [
          "Energy harvesting",
          "Lead magnesium niobate Pb",
          "(Mg1/3Nb2/3) O3-lead titnate",
          "PbTiO3 (PMN-PT)",
          "Perovskite structure",
          "Piezoelectric materials",
          "Relaxor-PT"
        ],
        "resource_type": {
          "title": "Journal article",
          "type": "publication",
          "subtype": "article"
        },
        "journal": {
          "issue": "1",
          "pages": "276-281",
          "title": "International Journal of Advances in Applied Sciences (IJAAS)",
          "volume": "14"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "14986744"
              }
            }
          ]
        }
      },
      "title": "Binary relaxor piezoceramic Pb (Mg1/3Nb2/3) O3-PbTiO3 for energy harvesting",
      "links": {
        "self": "https://zenodo.org/api/records/14986745",
        "self_html": "https://zenodo.org/records/14986745",
        "doi": "https://doi.org/10.11591/ijaas.v14.i1.pp276-281",
        "self_doi": "https://doi.org/10.11591/ijaas.v14.i1.pp276-281",
        "self_doi_html": "https://zenodo.org/doi/10.11591/ijaas.v14.i1.pp276-281",
        "parent": "https://zenodo.org/api/records/14986744",
        "parent_html": "https://zenodo.org/records/14986744",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:14986745/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:14986745/sequence/default",
        "files": "https://zenodo.org/api/records/14986745/files",
        "media_files": "https://zenodo.org/api/records/14986745/media-files",
        "thumbnails": {
          "10": "https://zenodo.org/api/iiif/record:14986745:30-21259%20IJAAS.pdf/full/^10,/0/default.jpg",
          "50": "https://zenodo.org/api/iiif/record:14986745:30-21259%20IJAAS.pdf/full/^50,/0/default.jpg",
          "100": "https://zenodo.org/api/iiif/record:14986745:30-21259%20IJAAS.pdf/full/^100,/0/default.jpg",
          "250": "https://zenodo.org/api/iiif/record:14986745:30-21259%20IJAAS.pdf/full/^250,/0/default.jpg",
          "750": "https://zenodo.org/api/iiif/record:14986745:30-21259%20IJAAS.pdf/full/^750,/0/default.jpg",
          "1200": "https://zenodo.org/api/iiif/record:14986745:30-21259%20IJAAS.pdf/full/^1200,/0/default.jpg"
        },
        "archive": "https://zenodo.org/api/records/14986745/files-archive",
        "archive_media": "https://zenodo.org/api/records/14986745/media-files-archive",
        "latest": "https://zenodo.org/api/records/14986745/versions/latest",
        "latest_html": "https://zenodo.org/records/14986745/latest",
        "versions": "https://zenodo.org/api/records/14986745/versions",
        "draft": "https://zenodo.org/api/records/14986745/draft",
        "reserve_doi": "https://zenodo.org/api/records/14986745/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/14986745/access/links",
        "access_grants": "https://zenodo.org/api/records/14986745/access/grants",
        "access_users": "https://zenodo.org/api/records/14986745/access/users",
        "access_request": "https://zenodo.org/api/records/14986745/access/request",
        "access": "https://zenodo.org/api/records/14986745/access",
        "communities": "https://zenodo.org/api/records/14986745/communities",
        "communities-suggestions": "https://zenodo.org/api/records/14986745/communities-suggestions",
        "requests": "https://zenodo.org/api/records/14986745/requests"
      },
      "updated": "2025-03-07T07:00:04.221290+00:00",
      "recid": "14986745",
      "revision": 4,
      "files": [
        {
          "id": "bbf05930-a44f-48af-a8a2-291b72026126",
          "key": "30-21259 IJAAS.pdf",
          "size": 365970,
          "checksum": "md5:b9d578eceac4d86b65c753bd33d10284",
          "links": {
            "self": "https://zenodo.org/api/records/14986745/files/30-21259 IJAAS.pdf/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "107604"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 2,
        "unique_downloads": 2,
        "views": 5,
        "unique_views": 5,
        "version_downloads": 2,
        "version_unique_downloads": 2,
        "version_unique_views": 5,
        "version_views": 5
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-03-04T14:08:06.031331+00:00",
      "modified": "2025-03-04T14:31:50.205828+00:00",
      "id": 14967142,
      "conceptrecid": "14967141",
      "doi": "10.1109/JSEN.2023.3300363",
      "doi_url": "https://doi.org/10.1109/JSEN.2023.3300363",
      "metadata": {
        "title": "Mathematical Model and Experimental Characterization of Vertically Stacked Capacitive Tactile Sensors",
        "doi": "10.1109/JSEN.2023.3300363",
        "publication_date": "2024-08-04",
        "description": "<p>Capacitive sensors are widely used in robotics for their compactness, high resolution, high sensitivity, and large dynamic range. In this article, we present a design solution for the manufacturing of capacitive tactile sensors with enhanced dynamic range and sensitivity. Herein, we adopted the approach of exploiting the vertical direction of the sensors by creating stacks of capacitors. The validation of the proposed model is conducted by means of finite element simulations and the effectiveness of stacked capacitors in suboptimal configurations has been experimentally tested by using inkjet printing and spin coating-based fabrication techniques. Results show that these sensors exhibit an enhanced dynamic range and sensitivity with respect to common single capacitors, for a given sensors area budget. Sensitivity increases of 235% passing from one-stack to two-stack capacitors (from 5.75 to 19.3 fF/kPa) and a growth of 23% from two-stack to three-stack capacitors (from 19.3 to 23.7 fF/kPa). These results suggest that the proposed methodology could be adopted for designing tactile sensors with higher spatial resolution and higher transduction sensitivity and dynamic range, in the perspective of an integration over large areas.</p>",
        "access_right": "open",
        "creators": [
          {
            "name": "Baldini, Giulia",
            "affiliation": null,
            "orcid": "0000-0001-7299-1665"
          },
          {
            "name": "Staiano, Marco",
            "affiliation": "University of Genoa"
          },
          {
            "name": "Grella, Francesco",
            "affiliation": "University of Genoa",
            "orcid": "0000-0002-4663-2690"
          },
          {
            "name": "Frascio, Mattia",
            "affiliation": "Universit\u00e0 degli Studi di Genova Scuola Politecnica",
            "orcid": "0000-0001-7069-6726"
          },
          {
            "name": "Maiolino, Perla",
            "affiliation": "Oxford Robotics Institute",
            "orcid": "0000-0002-7588-9567"
          },
          {
            "name": "Cannata, Giorgio",
            "affiliation": "University of Genoa",
            "orcid": "0000-0001-7932-5411"
          }
        ],
        "resource_type": {
          "title": "Journal article",
          "type": "publication",
          "subtype": "article"
        },
        "journal": {
          "issue": "18",
          "pages": "21341-21354",
          "title": "IEEE Sensors Journal",
          "volume": "23"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "communities": [
          {
            "id": "sestosenso"
          }
        ],
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "14967141"
              }
            }
          ]
        }
      },
      "title": "Mathematical Model and Experimental Characterization of Vertically Stacked Capacitive Tactile Sensors",
      "links": {
        "self": "https://zenodo.org/api/records/14967142",
        "self_html": "https://zenodo.org/records/14967142",
        "doi": "https://doi.org/10.1109/JSEN.2023.3300363",
        "self_doi": "https://doi.org/10.1109/JSEN.2023.3300363",
        "self_doi_html": "https://zenodo.org/doi/10.1109/JSEN.2023.3300363",
        "parent": "https://zenodo.org/api/records/14967141",
        "parent_html": "https://zenodo.org/records/14967141",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:14967142/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:14967142/sequence/default",
        "files": "https://zenodo.org/api/records/14967142/files",
        "media_files": "https://zenodo.org/api/records/14967142/media-files",
        "thumbnails": {
          "10": "https://zenodo.org/api/iiif/record:14967142:Mathematical_Model_and_Experimental_Characterization_of_Vertically_Stacked_Capacitive_Tactile_Sensors.pdf/full/^10,/0/default.jpg",
          "50": "https://zenodo.org/api/iiif/record:14967142:Mathematical_Model_and_Experimental_Characterization_of_Vertically_Stacked_Capacitive_Tactile_Sensors.pdf/full/^50,/0/default.jpg",
          "100": "https://zenodo.org/api/iiif/record:14967142:Mathematical_Model_and_Experimental_Characterization_of_Vertically_Stacked_Capacitive_Tactile_Sensors.pdf/full/^100,/0/default.jpg",
          "250": "https://zenodo.org/api/iiif/record:14967142:Mathematical_Model_and_Experimental_Characterization_of_Vertically_Stacked_Capacitive_Tactile_Sensors.pdf/full/^250,/0/default.jpg",
          "750": "https://zenodo.org/api/iiif/record:14967142:Mathematical_Model_and_Experimental_Characterization_of_Vertically_Stacked_Capacitive_Tactile_Sensors.pdf/full/^750,/0/default.jpg",
          "1200": "https://zenodo.org/api/iiif/record:14967142:Mathematical_Model_and_Experimental_Characterization_of_Vertically_Stacked_Capacitive_Tactile_Sensors.pdf/full/^1200,/0/default.jpg"
        },
        "archive": "https://zenodo.org/api/records/14967142/files-archive",
        "archive_media": "https://zenodo.org/api/records/14967142/media-files-archive",
        "latest": "https://zenodo.org/api/records/14967142/versions/latest",
        "latest_html": "https://zenodo.org/records/14967142/latest",
        "versions": "https://zenodo.org/api/records/14967142/versions",
        "draft": "https://zenodo.org/api/records/14967142/draft",
        "reserve_doi": "https://zenodo.org/api/records/14967142/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/14967142/access/links",
        "access_grants": "https://zenodo.org/api/records/14967142/access/grants",
        "access_users": "https://zenodo.org/api/records/14967142/access/users",
        "access_request": "https://zenodo.org/api/records/14967142/access/request",
        "access": "https://zenodo.org/api/records/14967142/access",
        "communities": "https://zenodo.org/api/records/14967142/communities",
        "communities-suggestions": "https://zenodo.org/api/records/14967142/communities-suggestions",
        "requests": "https://zenodo.org/api/records/14967142/requests"
      },
      "updated": "2025-03-04T14:31:50.205828+00:00",
      "recid": "14967142",
      "revision": 8,
      "files": [
        {
          "id": "6056653c-d330-41f5-a80a-8661d72a91e0",
          "key": "Mathematical_Model_and_Experimental_Characterization_of_Vertically_Stacked_Capacitive_Tactile_Sensors.pdf",
          "size": 2031137,
          "checksum": "md5:8155f72f2709c17d6ea8ff0f17070d23",
          "links": {
            "self": "https://zenodo.org/api/records/14967142/files/Mathematical_Model_and_Experimental_Characterization_of_Vertically_Stacked_Capacitive_Tactile_Sensors.pdf/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "1222851"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 9,
        "unique_downloads": 5,
        "views": 11,
        "unique_views": 8,
        "version_downloads": 9,
        "version_unique_downloads": 5,
        "version_unique_views": 8,
        "version_views": 11
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-03-01T08:30:58.634360+00:00",
      "modified": "2025-03-01T08:30:58.971960+00:00",
      "id": 14949287,
      "conceptrecid": "14949286",
      "doi": "10.3897/pharmacia.72.e145066",
      "doi_url": "https://doi.org/10.3897/pharmacia.72.e145066",
      "metadata": {
        "title": "Effects of capecitabine chemotherapy on the expression of CASC18, CASC19, and CASC20 lncRNAs in patients with colorectal cancer and the HCT-116 colorectal cancer cell line",
        "doi": "10.3897/pharmacia.72.e145066",
        "publication_date": "2025-02-27",
        "description": "<p>      Background: Colorectal cancer (CRC) is the third leading cause of cancer-related deaths. Capecitabine is a key chemotherapy drug for colorectal cancer (CRC). Long non-coding RNAs (lncRNAs) play a role in the pathogenic pathways associated with colorectal cancer. This investigation compared the expression patterns of CASC18, CASC19, and CASC20 in CRC patients before and after chemotherapy, as well as in healthy individuals. The effects of capecitabine on cell viability, apoptosis, cell cycle, and the expressions of CASC18, CASC19, and CASC20 were examined using HCT-116 cells.</p>     <p>      Methods: CASC18, CASC19, and CASC20 expressions were assessed using qRT-PCR on patients' and healthy tissues. Furthermore, the receiver operating characteristic (ROC) curve analysis was used to evaluate the prognostic and diagnostic value of CASC18, CASC19, and CASC20 in CRC. The MTT test was used to assess capecitabine's cytotoxicity on the HCT-116 CRC cell line. Annexin-V/PI staining was used to examine apoptosis and cell cycle progression by flow cytometry. Gene expression differences between before and after capecitabine treatments were examined by qRT-PCR.</p>     <p>      Results: Results showed that patients with colorectal cancer had lower levels of CASC18 but higher levels of CASC19 and CASC20 expression than the healthy group. Moreover, patients treated with capecitabine showed an increased CASC18 expression, while non-significant changes were observed in the expression of CASC19 and CASC20. The clinical factors were not associated with the expression of lncRNAs CASC18, CASC19, and CASC20. Furthermore, results indicated that CASC18, CASC19, and CASC20 are poor biomarkers for diagnosis of CRC. MTT analysis revealed a dose- and time-dependent cytotoxic effect for capecitabine on the HCT-116 cells. Capecitabine treatment led to the accumulation of the HCT-116 cells in the Sub-G1 phase, suggesting an apoptotic solid impact on the cells. Moreover, HCT-116 cells were arrested in the G2/M phases by capecitabine. Capecitabine also upregulated CASC18 expression in the HCT-116 cell line.</p>     <p>      Conclusion: These results support the anticancer and cytotoxic effects of capecitabine and highlight its ability to increase CASC18 expression. Additionally, the findings indicate that CASC18, CASC19, and CASC20 are poor biomarkers for colorectal cancer (CRC) diagnosis.</p>",
        "access_right": "open",
        "creators": [
          {
            "name": "Chayd, Nafea M.",
            "affiliation": "University of Tabriz, Tabriz, Iran"
          },
          {
            "name": "Khalaj-Kondori, Mohammad",
            "affiliation": "University of Tabriz, Tabriz, Iran"
          },
          {
            "name": "Safaralizadeh, Reza",
            "affiliation": "University of Tabriz, Tabriz, Iran"
          },
          {
            "name": "Hosseinpour Feizi, Mohammad Ali",
            "affiliation": "University of Tabriz, Tabriz, Iran"
          }
        ],
        "keywords": [
          "Colorectal cancer",
          "CASC18",
          "CASC19",
          "CASC20",
          "capecitabine",
          "apoptosis",
          "cell cycle"
        ],
        "related_identifiers": [
          {
            "identifier": "10.3897/pharmacia.72.e145066.figure1",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.3897/pharmacia.72.e145066.figure5",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.3897/pharmacia.72.e145066.figure4",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.3897/pharmacia.72.e145066.figure2",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.3897/pharmacia.72.e145066.figure6",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.3897/pharmacia.72.e145066.figure3",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.14218/ge.2023.00084",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1007/s00210-024-03674-8",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3892/or.2023.8612",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1007/s13577-020-00409-8",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1001/jamaoncol.2016.5688",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1093/annonc/mdx261.299",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1186/s12935-023-02853-6",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1002/cbin.11692.",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1080/15257770.2021.1956530",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1177/1756284820917527",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3892/etm.2020.8518",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.ejca.2007.10.023",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1097/HCO.0000000000000454",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.molcel.2017.09.015",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1007/s12079-023-00794-3",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.61186/rbmb.12.4.664",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.22038/ijbms.2023.71259.15482",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1007/s11033-023-08742-5",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1007/s11033-022-07396-z",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.cell.2018.01.011",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1002/cbin.10890",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.gene.2016.12.008",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.5812/jjcmb-141522",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1007/s11033-021-06488-6",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3389/fmed.2023.1086097",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.lfs.2023.122083",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.jss.2007.04.021",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1186/s13046-018-0725-3",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3748/wjg.v28.i16.1656",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3322/caac.21395",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/s41467-020-15547-8",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3881/j.issn.1000-503X.2017.06.004",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1002/jgm.3254",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1007/s12094-023-03165-x",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.18632/aging.102190",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/s41392-020-0116-z",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1002/ijc.32747",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1186/s12943-020-1146-4",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1007/s00210-024-03145-0",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.18632/oncotarget.15161",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3389/fimmu.2021.737849",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1186/s10020-021-00345-9",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          }
        ],
        "references": [
          "Ahmadi A, Moqadami A, Khalaj-Kondori M, Ghiasvand S (2024) Non-coding RNAs affect breast cancer development through the notch signaling pathway: An overview. Gene Expression 23: 44\u201356. https://doi.org/10.14218/ge.2023.00084",
          "Alkharsan AMHms, Safaralizadeh R, Khalaj-Kondori M, HosseinpourFeizi M (2024) Examination of the effects of capecitabine treatment on the HT-29 colorectal cancer cell line and HCG 11, HCG 15, and HCG 18 lncRNAs in CRC patients before and after chemotherapy. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03674-8",
          "Alzahrani SM, Al Doghaither HA, Al-Ghafari AB, Pushparaj PN (2023) 5\u2011Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review). Oncology Reports 50. https://doi.org/10.3892/or.2023.8612",
          "Feng Y, Wu M, Hu S, Peng X, Chen F (2020) LncRNA DDX11-AS1: a novel oncogene in human cancer. Human Cell 33: 946\u2013953. https://doi.org/10.1007/s13577-020-00409-8",
          "Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L, Fleming T, Forouzanfar MH, Hancock J, Hay RJ, Hunter-Merrill R, Huynh C, Hosgood HD, Johnson CO, Jonas JB, Khubchandani J, Kumar GA, Kutz M, Lan Q, Larson HJ, Liang X, Lim SS, Lopez AD, MacIntyre MF, Marczak L, Marquez N, Mokdad AH, Pinho C, Pourmalek F, Salomon JA, Sanabria JR, Sandar L, Sartorius B, Schwartz SM, Shackelford KA, Shibuya K, Stanaway J, Steiner C, Sun J, Takahashi K, Vollset SE, Vos T, Wagner JA, Wang H, Westerman R, Zeeb H, Zoeckler L, Abd-Allah F, Ahmed MB, Alabed S, Alam NK, Aldhahri SF, Alem G, Alemayohu MA, Ali R, Al-Raddadi R, Amare A, Amoako Y, Artaman A, Asayesh H, Atnafu N, Awasthi A, Saleem HB, Barac A, Bedi N, Bensenor I, Berhane A, Bernab\u00e9 E, Betsu B, Binagwaho A, Boneya D, Campos-Nonato I, Casta\u00f1eda-Orjuela C, Catal\u00e1-L\u00f3pez F, Chiang P, Chibueze C, Chitheer A, Choi JY, Cowie B, Damtew S, das Neves J, Dey S, Dharmaratne S, Dhillon P, Ding E, Driscoll T, Ekwueme D, Endries AY, Farvid M, Farzadfar F, Fernandes J, Fischer F, TT GH, Gebru A, Gopalani S, Hailu A, Horino M, Horita N, Husseini A, Huybrechts I, Inoue M, Islami F, Jakovljevic M, James S, Javanbakht M, Jee SH, Kasaeian A, Kedir MS, Khader YS, Khang YH, Kim D, Leigh J, Linn S, Lunevicius R, El Razek HMA, Malekzadeh R, Malta DC, Marcenes W, Markos D, Melaku YA, Meles KG, Mendoza W, Mengiste DT, Meretoja TJ, Miller TR, Mohammad KA, Mohammadi A, Mohammed S, Moradi-Lakeh M, Nagel G, Nand D, Le Nguyen Q, Nolte S, Ogbo FA, Oladimeji KE, Oren E, Pa M, Park EK, Pereira DM, Plass D, Qorbani M, Radfar A, Rafay A, Rahman M, Rana SM, S\u00f8reide K, Satpathy M, Sawhney M, Sepanlou SG, Shaikh MA, She J, Shiue I, Shore HR, Shrime MG, So S, Soneji S, Stathopoulou V, Stroumpoulis K, Sufiyan MB, Sykes BL, Tabar\u00e9s-Seisdedos R, Tadese F, Tedla BA, Tessema GA, Thakur JS, Tran BX, Ukwaja KN, Uzochukwu BSC, Vlassov VV, Weiderpass E, Wubshet Terefe M, Yebyo HG, Yimam HH, Yonemoto N, Younis MZ, Yu C, Zaidi Z, Zaki MES, Zenebe ZM, Murray CJL, Naghavi M (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncology 3: 524\u2013548. https://doi.org/10.1001/jamaoncol.2016.5688",
          "Garajov\u00e1 I, Frega G, Palloni A, Abbati F, Massucci M, Mollica V, Brandi G, Biasco G (2017) P-302The best overall response to the first-line but not to the second-line treatment correlates with outcome of metastatic right-sided and left-sided colon cancer. Annals of Oncology 28: iii105\u2013iii106. https://doi.org/10.1093/annonc/mdx261.299",
          "Ge C, Huang X, Zhang S, Yuan M, Tan Z, Xu C, Jie Q, Zhang J, Zou J, Zhu Y, Feng D, Zhang Y, Aa J (2023) In vitro co-culture systems of hepatic and intestinal cells for cellular pharmacokinetic and pharmacodynamic studies of capecitabine against colorectal cancer. Cancer Cell International 23: 14. https://doi.org/10.1186/s12935-023-02853-6",
          "Ghasemi T, Khalaj-Kondori M, Hosseinpour Feizi MA, Asadi P (2021a) Aberrant expression of lncRNAs SNHG6, TRPM2-AS1, MIR4435-2HG, and hypomethylation of TRPM2-AS1 promoter in colorectal cancer. Cell Biology International 45: 2464\u20132478. https://doi.org/10.1002/cbin.11692.",
          "Ghasemi T, Khalaj-Kondori M, Hosseinpour Feizi MA, Asadi P (2021b) Long non-coding RNA AGAP2-AS1 is up regulated in colorectal cancer. Nucleosides Nucleotides Nucleic Acids 40: 829\u2013844. https://doi.org/10.1080/15257770.2021.1956530",
          "Golshani G, Zhang Y (2020) Advances in immunotherapy for colorectal cancer: a review. Therap Adv Gastroenterol 13: 1756284820917527. https://doi.org/10.1177/1756284820917527",
          "Grothey A, Marshall JL, Bekaii-Saab T (2019) Sequencing beyond the second-line setting in metastatic colorectal cancer. Clinical Advances in Hematology & Oncology 17(Suppl 7): 1\u201319.",
          "Gu C, Zou S, He C, Zhou J, Qu R, Wang Q, Qi J, Zhou M, Yan S, Ye Z (2020) Long non-coding RNA CCAT1 promotes colorectal cancer cell migration, invasiveness and viability by upregulating VEGF via negative modulation of microRNA-218. Experimental and Therapeutic Medicine 19: 2543\u20132550. https://doi.org/10.3892/etm.2020.8518",
          "Guichard SM, Macpherson JS, Mayer I, Reid E, Muir M, Dodds M, Alexander S, Jodrell DI (2008) Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity. European Journal of Cancer 44: 310\u2013317. https://doi.org/10.1016/j.ejca.2007.10.023",
          "Haemmig S, Simion V, Yang D, Deng Y, Feinberg MW (2017) Long noncoding RNAs in cardiovascular disease, diagnosis, and therapy. Curr Opin Cardiol 32: 776\u2013783. https://doi.org/10.1097/HCO.0000000000000454",
          "Huang JZ, Chen M, Chen D, Gao XC, Zhu S, Huang H, Hu M, Zhu H, Yan GR (2017) A peptide encoded by a putative lncRNA HOXB-AS3 suppresses colon cancer growth. Molecular Cell 68: 171\u2013184.e6. https://doi.org/10.1016/j.molcel.2017.09.015",
          "Jahangiri B, Khalaj-Kondori M, Asadollahi E, Kian Saei A, Sadeghizadeh M (2023) Dual impacts of mesenchymal stem cell-derived exosomes on cancer cells: unravelling complex interactions. Journal of Cell Communication and Signaling 17: 1229\u20131247. https://doi.org/10.1007/s12079-023-00794-3",
          "Kadhum Kharmeet B, Khalaj-Kondori M, Hoseinpour Feizi MA, Hajavi J (2024) 5-fluorouracil-loaded PLGA declined expression of pro-inflammatory genes IL-9, IL-17A, IL-23 and IFN- y; in the HT-29 colon cancer cell line. Reports of Biochemistry and Molecular Biology 12: 664\u2013673. https://doi.org/10.61186/rbmb.12.4.664",
          "Karimpur Zahmatkesh A, Moqadami A, Khalaj-Kondori M (2023) Insights into the radiotherapy-induced deferentially expressed RNAs in colorectal cancer management. Iranian Journal of Basic Medical Sciences 26: 1380\u20131389. https://doi.org/10.22038/ijbms.2023.71259.15482",
          "Khajehdehi M, Khalaj-Kondori M, Baradaran B (2023) The siRNA-mediated knockdown of SNHG4 efficiently induced pro-apoptotic signaling and suppressed metastasis in SW1116 colorectal cancer cell line. Molecular Biology Reports 50: 8995\u20139006. https://doi.org/10.1007/s11033-023-08742-5",
          "Khajehdehi M, Khalaj-Kondori M, Hosseinpour Feizi MA (2022) Expression profiling of cancer-related long non-coding RNAs revealed upregulation and biomarker potential of HAR1B and JPX in colorectal cancer. Molecular Biology Reports 49: 6075\u20136084. https://doi.org/10.1007/s11033-022-07396-z",
          "Kopp F, Mendell JT (2018) Functional classification and experimental dissection of long noncoding RNAs. Cell 172: 393\u2013407. https://doi.org/10.1016/j.cell.2018.01.011",
          "Lai Y, Chen Y, Lin Y, Ye L (2018) Down-regulation of LncRNA CCAT1 enhances radiosensitivity via regulating miR-148b in breast cancer. Cell Biology International 42: 227\u2013236. https://doi.org/10.1002/cbin.10890",
          "Mehravar M, Jafarzadeh M, Kay M, Najafi H, Hoseini F, Mowla SJ, Soltani B (2016) Introduction of novel splice variants for CASC18 gene and its relation to the neural differentiation. Gene 603: 27\u201333. https://doi.org/10.1016/j.gene.2016.12.008",
          "Moqadami A, Ahmadi A, Khalaj-Kondori M (2023) lncRNA VLDLR-AS1 gene expression in colorectal cancer in patients from East Azerbaijan Province, Iran. Jentashapir Journal of Cellular and Molecular Biology 14: e141522. https://doi.org/10.5812/jjcmb-141522",
          "Ostovarpour M, Khalaj-Kondori M, Ghasemi T (2021) Correlation between expression levels of lncRNA FER1L4 and RB1 in patients with colorectal cancer. Molecular Biology Reports 48: 4581\u20134589. https://doi.org/10.1007/s11033-021-06488-6",
          "Partin A, Brettin TS, Zhu Y, Narykov O, Clyde A, Overbeek J, Stevens RL (2023) Deep learning methods for drug response prediction in cancer: Predominant and emerging trends. Frontiers in Medicine 10: 1086097. https://doi.org/10.3389/fmed.2023.1086097",
          "Pouya FD, Salehi R, Rasmi Y, Kheradmand F, Fathi-Azarbayjani A (2023) Combination chemotherapy against colorectal cancer cells: Co-delivery of capecitabine and pioglitazone hydrochloride by polycaprolactone-polyethylene glycol carriers. Life Sciences 332: 122083. https://doi.org/10.1016/j.lfs.2023.122083",
          "Rajput A, Dominguez San Martin I, Rose R, Beko A, LeVea C, Sharratt E, Mazurchuk R, Hoffman RM, Brattain MG, Wang J (2008) Characterization of HCT116 human colon cancer cells in an orthotopic model. Journal of Surgical Research 147: 276\u2013281. https://doi.org/10.1016/j.jss.2007.04.021",
          "Sha M, Lin M, Wang J, Ye J, Xu J, Xu N, Huang J (2018) Long non-coding RNA MIAT promotes gastric cancer growth and metastasis through regulation of miR-141/DDX5 pathway. Journal of Experimental & Clinical Cancer Research 37: 58. https://doi.org/10.1186/s13046-018-0725-3",
          "Shan KS, Li WW, Ren W, Kong S, Peng LP, Zhuo HQ, Tian SB (2022) LncRNA cancer susceptibility 20 regulates the metastasis of human gastric cancer cells via the miR-143-5p/MEMO1 molecular axis. World Journal of Gastroenterology 28: 1656\u20131670. https://doi.org/10.3748/wjg.v28.i16.1656",
          "Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A (2017) Colorectal cancer statistics, 2017. CA: A Cancer Journal for Clinicians 67: 177\u2013193. https://doi.org/10.3322/caac.21395",
          "Silva-Fisher JM, Dang HX, White NM, Strand MS, Krasnick BA, Rozycki EB, Jeffers GGL, Grossman JG, Highkin MK, Tang C, Cabanski CR, Eteleeb A, Mudd J, Goedegebuure SP, Luo J, Mardis ER, Wilson RK, Ley TJ, Lockhart AC, Fields RC, Maher CA (2020) Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression. Nature Communications 11: 2156. https://doi.org/10.1038/s41467-020-15547-8",
          "Suat \u00d6vey \u0130, G\u00fcler Y (2020) Apoptotic efficiency of capecitabine and 5-fluorouracil on human cancer cells through TRPV1 channels. Indian Journal of Biochemistry and Biophysics (IJBB) 57: 64\u201372.",
          "Wang JJ, Li XM, He L, Zhong SZ, Peng YX, Ji N (2017) Expression and Function of Long Non-coding RNA CASC19 in Colorectal Cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 39: 756\u2013761. https://doi.org/10.3881/j.issn.1000-503X.2017.06.004",
          "Wang L, Lin C, Sun N, Wang Q, Ding X, Sun Y (2020) Long non-coding RNA CASC19 facilitates non-small cell lung cancer cell proliferation and metastasis by targeting the miR-301b-3p/LDLR axis.The Journal of Gene Medicine 22: e3254. https://doi.org/10.1002/jgm.3254",
          "Wang S, Qiao C, Fang R, Yang S, Zhao G, Liu S, Li P (2023) LncRNA CASC19: a novel oncogene involved in human cancer. Clinical and Translational Oncology 25: 2841\u20132851. https://doi.org/10.1007/s12094-023-03165-x",
          "Wang WJ, Guo CA, Li R, Xu ZP, Yu JP, Ye Y, Zhao J, Wang J, Wang WA, Zhang A, Li HT, Wang C, Liu HB (2019) Long non-coding RNA CASC19 is associated with the progression and prognosis of advanced gastric cancer. Aging (Albany NY) 11: 5829\u20135847. https://doi.org/10.18632/aging.102190",
          "Xie Y-H, Chen Y-X, Fang J-Y (2020) Comprehensive review of targeted therapy for colorectal cancer. Signal Transduction and Targeted Therapy 5: 22. https://doi.org/10.1038/s41392-020-0116-z",
          "Xu W, Zhou G, Wang H, Liu Y, Chen B, Chen W, Lin C, Wu S, Gong A, Xu M (2020) Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer. International Journal of Cancer 146: 2901\u20132912. https://doi.org/10.1002/ijc.32747",
          "Yang X, Zhang S, He C, Xue P, Zhang L, He Z, Zang L, Feng B, Sun J, Zheng M (2020) METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST. Molecular Cancer 19: 46. https://doi.org/10.1186/s12943-020-1146-4",
          "Zehra K, Banu A, Can E, H\u00fclya C (2024) Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines. Naunyn-Schmiedeberg's Archives of Pharmacology 397: 7913\u20137926. https://doi.org/10.1007/s00210-024-03145-0",
          "Zeng JH, Liang L, He RQ, Tang RX, Cai XY, Chen JQ, Luo DZ, Chen G (2017) Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma. Oncotarget 8: 16811\u201316828. https://doi.org/10.18632/oncotarget.15161",
          "Zhang S, Wang Z, Fan S, Liu T, Yoshida S, Yang S, Liu L, Hou W, Cao L, Wang J, Song Z, Li S, Zhang S, Wang H, Li J, Zheng H, Shen Z (2021) Capecitabine Can Induce T Cell Apoptosis: A Potential Immunosuppressive Agent With Anti-Cancer Effect. Frontiers in Immunology 12: 737849. https://doi.org/10.3389/fimmu.2021.737849",
          "Zhou B, Zhou Y, Liu Y, Zhang H, Mao H, Peng M, Xu A, Li Z, Wang H, Tan H, Ren H, Zhou X, Long Y (2021) Association of CASC18/miR-20a-3p/TGFB2 ceRNA axis with occult lymph node metastasis in tongue squamous cell carcinoma. Molecular Medicine 27: 85. https://doi.org/10.1186/s10020-021-00345-9"
        ],
        "resource_type": {
          "title": "Journal article",
          "type": "publication",
          "subtype": "article"
        },
        "journal": {
          "issue": "",
          "pages": "1-13",
          "title": "Pharmacia",
          "volume": "72"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "14949286"
              }
            }
          ]
        }
      },
      "title": "Effects of capecitabine chemotherapy on the expression of CASC18, CASC19, and CASC20 lncRNAs in patients with colorectal cancer and the HCT-116 colorectal cancer cell line",
      "links": {
        "self": "https://zenodo.org/api/records/14949287",
        "self_html": "https://zenodo.org/records/14949287",
        "doi": "https://doi.org/10.3897/pharmacia.72.e145066",
        "self_doi": "https://doi.org/10.3897/pharmacia.72.e145066",
        "self_doi_html": "https://zenodo.org/doi/10.3897/pharmacia.72.e145066",
        "parent": "https://zenodo.org/api/records/14949286",
        "parent_html": "https://zenodo.org/records/14949286",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:14949287/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:14949287/sequence/default",
        "files": "https://zenodo.org/api/records/14949287/files",
        "media_files": "https://zenodo.org/api/records/14949287/media-files",
        "thumbnails": {
          "10": "https://zenodo.org/api/iiif/record:14949287:PHAR_article_145066.pdf/full/^10,/0/default.jpg",
          "50": "https://zenodo.org/api/iiif/record:14949287:PHAR_article_145066.pdf/full/^50,/0/default.jpg",
          "100": "https://zenodo.org/api/iiif/record:14949287:PHAR_article_145066.pdf/full/^100,/0/default.jpg",
          "250": "https://zenodo.org/api/iiif/record:14949287:PHAR_article_145066.pdf/full/^250,/0/default.jpg",
          "750": "https://zenodo.org/api/iiif/record:14949287:PHAR_article_145066.pdf/full/^750,/0/default.jpg",
          "1200": "https://zenodo.org/api/iiif/record:14949287:PHAR_article_145066.pdf/full/^1200,/0/default.jpg"
        },
        "archive": "https://zenodo.org/api/records/14949287/files-archive",
        "archive_media": "https://zenodo.org/api/records/14949287/media-files-archive",
        "latest": "https://zenodo.org/api/records/14949287/versions/latest",
        "latest_html": "https://zenodo.org/records/14949287/latest",
        "versions": "https://zenodo.org/api/records/14949287/versions",
        "draft": "https://zenodo.org/api/records/14949287/draft",
        "reserve_doi": "https://zenodo.org/api/records/14949287/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/14949287/access/links",
        "access_grants": "https://zenodo.org/api/records/14949287/access/grants",
        "access_users": "https://zenodo.org/api/records/14949287/access/users",
        "access_request": "https://zenodo.org/api/records/14949287/access/request",
        "access": "https://zenodo.org/api/records/14949287/access",
        "communities": "https://zenodo.org/api/records/14949287/communities",
        "communities-suggestions": "https://zenodo.org/api/records/14949287/communities-suggestions",
        "requests": "https://zenodo.org/api/records/14949287/requests"
      },
      "updated": "2025-03-01T08:30:58.971960+00:00",
      "recid": "14949287",
      "revision": 4,
      "files": [
        {
          "id": "05ee7320-ac0c-4fa7-ba36-3dcb8975bd28",
          "key": "PHAR_article_145066.pdf",
          "size": 1649113,
          "checksum": "md5:ec4c7670f664b0a9b73bf31c66b62ea5",
          "links": {
            "self": "https://zenodo.org/api/records/14949287/files/PHAR_article_145066.pdf/content"
          }
        },
        {
          "id": "9c242890-e974-4380-8892-7177a0716942",
          "key": "PHAR_article_145066.xml",
          "size": 139505,
          "checksum": "md5:5293080e0067ead483b4ae79ad12b874",
          "links": {
            "self": "https://zenodo.org/api/records/14949287/files/PHAR_article_145066.xml/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "22270"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 13,
        "unique_downloads": 13,
        "views": 5,
        "unique_views": 5,
        "version_downloads": 13,
        "version_unique_downloads": 13,
        "version_unique_views": 5,
        "version_views": 5
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-03-01T04:45:23.131280+00:00",
      "modified": "2025-03-01T09:17:45.545443+00:00",
      "id": 14948534,
      "conceptrecid": "14948533",
      "doi": "10.5281/zenodo.14948534",
      "conceptdoi": "10.5281/zenodo.14948533",
      "doi_url": "https://doi.org/10.5281/zenodo.14948534",
      "metadata": {
        "title": "Therapy of asthma and Hypersensitivity Responses",
        "doi": "10.5281/zenodo.14948534",
        "publication_date": "2025-03-01",
        "description": "<p>&nbsp;</p>\n<p><strong>&nbsp;</strong></p>\n<p><strong>Abstract</strong></p>\n<p>An improper reaction against harmless environmental proteins causes allergies. All around the world, allergic disorders have become epidemics. The pathophysiology of allergic hypersensitivity reactions is significantly influenced by allergen-specific T helper (Th) cells. Knowing the cellular and soluble mediators that contribute to allergic inflammatory responses is crucial for identifying new targets that can be targeted by biological and small-molecule therapies, as well as for comprehending the mechanisms underlying existing treatments. Because of advancements in systemic and mucosal allergen-specific immunotherapy, the discovery of important cytokines and their receptors that promote T-helper-2-cell polarization, a better comprehension of the signaling pathways involved in cell activation and mediator secretion, leukocyte recruitment pathways, and novel vaccine development strategies, there is now a great deal of hope for combating the allergy epidemic.</p>\n<p>&nbsp;</p>\n<p><strong>&nbsp;</strong></p>\n<p><strong>&nbsp;</strong></p>\n<p>&nbsp;</p>\n<p><strong>&nbsp;</strong></p>\n<p><strong>1.&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Introduction</strong></p>\n<p>The type-I allergic airway illness known as asthma is characterized by eosinophilic bronchial inflammation and is mediated by Th2 cells and IgE. The chronic inflammation and subsequent airway remodeling might cause symptoms to linger and lung function to decline in a significant majority of individuals (Bogaert, Tournoy <em>et al.</em> 2009).</p>\n<p>Asthma and other allergy illnesses have become much more common in recent decades, impacting an estimated 20% of the population in affluent nations. An abnormal immune response against harmless environmental proteins (antigens) is the cause of allergic disorders. Even though we are all constantly exposed to innocuous antigens, only a small portion of people have negative immune reactions to them. This is because the induction of tolerance is linked to the natural immunological response to allergens. Active immunological responses may be induced and sustained if tolerance is revoked or if tolerance is not induced. It is thought that allergen-specific CD4+ T lymphocytes are essential for the onset of asthma. Patients with allergies often have a high frequency of activated allergen-specific T cells in their peripheral blood. The increased synthesis of interleukin (IL)-4, IL-5, IL-9, and IL-13 (Th2 cytokines) is a characteristic of the allergen-specific CD4+ T cells implicated in the onset of allergic reactivity (Romagnani 2000).</p>\n<p>It is clear that more people are suffering from allergy illnesses, particularly in developed nations. There have been several theories put up to account for this rise in prevalence. One major claim is the \"hygiene hypothesis,\" which holds that better public health initiatives, greater hygiene, and the use of vaccinations and medicines have all contributed to a decrease in the prevalence of illnesses that would typically trigger the immune system. In order to prevent allergic reactions to harmless environmental chemicals, these infections would \"mature\" the immune system (Strachan 1989).</p>\n<p>High Th2 cytokine levels are one factor contributing to the clinical manifestations of allergy pathogenesis. The development of allergic and asthmatic inflammatory responses is influenced by environmental factors, including exposure to allergens, infections, and air pollution, even though genetic predisposition is the primary determinant for the development of allergy and asthma (Sampson 2004).</p>\n<p>Since \"reagin\" was first described in 1922 and later identified as IgE in 1966, significant progress has been made in our understanding of the chemical mediators involved, the immunological pathways leading to allergy, and the innate and adaptive immune responses that control its expression. Understanding the structure and intrinsic biology of environmental agents that dictate their allergenicity as well as the function of other environmental elements like pollution and microbes in enhancing or reducing allergen sensitization has also advanced (Eder, Ege <em>et al.</em> 2006).</p>\n<p>&nbsp;Since the majority of allergic diseases manifest clinically at mucosal or epidermal surfaces, a disruption of the physical barrier that these surfaces typically offer as well as changes in innate immunity are acknowledged to play a significant role in allergic reactions. The investigation of the relationships between many susceptibility genes and the environment is exposing novel pathophysiological processes and opening up fresh avenues for allergy treatment and prevention. The time has come to examine the new treatment approaches that are currently emerging from a different angle. This review offers a summary of potential novel therapeutics, with particular attention to some intriguing new molecular and immunological targets as well as vaccine strategies for asthma and allergies.</p>\n<p><strong>2.&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>The series of allergic reaction</strong></p>\n<p>The TH2-cell pathway, which is selected for the allergic inflammatory response, is started by professional antigen-presenting cells (APCs) absorbing allergens and presenting specific peptides on MHC class II molecules to naive T cells. This leads to a TH2-cell phenotype, where cytokine secretion is mediated by the transcription factor GATA3 (GATA-binding protein 3) (Hammad and Lambrecht 2006). In contrast, T-bet regulates the release of cytokines, such as interferon-&gamma; (IFN&gamma;), in the TH1-cell phenotype that predominates in autoimmune disorders. As professional APCs, dendritic cells (DCs) play a critical part in this sensitization process. Hamida Hammad and Bart Lambrecht address this in this issue. B cells are also crucial for the processing and capture of allergens, particularly when there are trace levels of the allergen present (von Garnier, Wikstrom <em>et al. </em>2007).</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p><strong>&nbsp;</strong></p>\n<p><strong>Figure.1 Allergic mechanisms. </strong>The activation of allergen-specific T helper 2 (TH2) cells and IgE synthesis, also referred to as allergic sensitization, are the primary outcomes of professional antigen-presenting cells' (APCs') first contact to an allergen in susceptible individuals. The early (acute) and late allergic reactions are brought on by the recruitment, activation, and release of mediators of inflammatory cells following subsequent allergen stimulation. Within minutes of coming into touch with an allergen, IgE-sensitized mast cells degranulate in the early allergic reaction, releasing mediators that have already been created as well as those that have been synthesized in sensitized individuals. These include cytokines, histamine, and cysteinyl leukotrienes, which encourage the creation of mucus, smooth muscle contraction, and vascular permeability. The recruitment of inflammatory cells that support the late allergy response&mdash;which is marked by an influx of TH2 cells and eosinophils&mdash;is guided by chemokines generated by mast cells and other cell types. Eosinophils may be a significant source of pro-inflammatory cytokines like interleukin-3 (IL-3), IL-5, and IL-13. They also release a variety of pro-inflammatory mediators, such as cysteinyl leukotrienes and basic proteins (eosinophil peroxidase, cationic proteins, major basic protein, and eosinophil-derived neurotoxin). Some of the pathogenic characteristics in individuals with chronic forms of atopy, such as smooth-muscle cell activation and epithelial apoptosis, may also be caused by TH1-cell responses, according to new research. The inhibition of TH2-cell responses in humans involving the inhibitory cytokines transforming growth factor-&beta; (TGF&beta;) and IL-10 is influenced by regulatory T (TReg) cells, another significant component of CD4+ T cells. The neutrophilic inflammatory processes that take place during disease aggravation and tissue remodeling appear to be especially linked to TH17 cells, another recently discovered CD4+ T-cell subset identified based on release of IL-17A and IL-17F. TCR stands for T-cell receptor; TNF for tumor-necrosis factor; IFN&gamma; for interferon-&gamma;; and FceRI for high-affinity receptor for IgE.</p>\n<p><strong>3.&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Theraputic Treatments</strong></p>\n<p><strong>&nbsp;3.1 Formulated treatments</strong></p>\n<p>&nbsp;According to disease-management recommendations, the cornerstones of asthma treatment today are inhaled corticosteroids and short- and long-acting &beta;2-adrenoceptor agonists (SABAs and LABAs). Non-sedating H1-antihistamines and topical corticosteroids are well-established control treatments for rhinitis, whereas &alpha;-adrenoceptor agonists are used to reduce nasal congestion. Therefore, the foundation of care guidelines for the majority of allergic illnesses is a combination of symptom-relieving and control therapy. An excellent illustration of how knowledge of the pathophysiology of the condition has supported current treatment strategies is asthma (Barnes, Chung <em>et al. </em>1998).</p>\n<p><strong>Corticosteroids: </strong>By suppressing the expression of cytokines, chemokines, and adhesion molecules37, whose encoding genes are controlled by transcription factors like nuclear factor-&kappa;B (NF-&kappa;B) and activator protein 1 (AP1), corticosteroids reduce TH2-cell-mediated inflammation in asthmatic airways. Diffusing through the cell membrane, free corticosteroids engage with cytoplasmic glucocorticoid receptors. This causes these receptors to become activated and then go into the nucleus, where a variety of processes, including as gene transactivation and gene transrepression, regulate the transcriptional activity of target genes (Barnes and Adcock 1998).<strong> </strong>Even when treatment is initiated early in childhood, inhaled corticosteroids have no effect on the disease's natural course, despite their great efficacy in reducing airway inflammation. <br>When it comes to viral exacerbations and asthmatics who smoke, inhaled corticosteroids are mainly ineffective(Barnes and Adcock 2003).</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p><strong>Figure.2</strong>. <strong>Anti-inflammatory actions of corticosteroids. </strong>When corticosteroids enter a cell, they attach to the cytoplasmic glucocorticoid receptor (GR) and go into the nucleus, where they start the transcription of target genes. There are glucocorticosteroid response elements (GREs) in the promoters of several genes. Annexin-1 (lipocortin-1), secretory leukoprotease inhibitor (SLPI), interleukin-10 (IL-10), and the inhibitor of nuclear factor-&kappa;B (I&kappa;B&alpha;) are examples of anti-inflammatory mediators that are transcriptionally activated when the activated glucocorticoid receptor homodimer binds to a GRE in the promoter region of steroid-sensitive genes. By interacting with large co-activator molecules that have intrinsic histone acetyltransferase (HAT) activity (like cyclic AMP response element binding protein, or CBP) and are activated by proinflammatory transcription factors (like NF-&kappa;B and AP1), the glucocorticoid receptor&ndash;corticosteroid complex transrepresses the expression of the inflammatory genes that these transcription factors activate. RNA polymerase II and RNA pol II.</p>\n<p><strong>&beta;2-adrenoceptor agonists: </strong>For the quick alleviation of asthma symptoms, inhaled SABAs like salbutamol and turbutaline are the best bronchodilators on the market right now. Protein kinase A is activated when these agonists bind to the &beta;2-adrenoceptor and the signal-transducing Gs protein stimulates adenylate cyclase to promote the generation of cyclic adenosine 3&prime;5&prime;-monophosphate (cAMP). This improves bronchoconstriction in asthma via phosphorylating myosin light-chain kinase and opening Ca2+-dependent K+ (KCa) channels, which causes smooth-muscle relaxation. For the quick alleviation of asthma symptoms, inhaled SABAs like salbutamol and turbutaline are the best bronchodilators on the market right now (Palmqvist, Persson <em>et al. </em>1997). Protein kinase A is activated when these agonists bind to the &beta;2-adrenoceptor and the signal-transducing Gs protein stimulates adenylate cyclase to promote the generation of cyclic adenosine 3&prime;5&prime;-monophosphate (cAMP). This improves bronchoconstriction in asthma via phosphorylating myosin light-chain kinase and opening Ca2+-dependent K+ (KCa) channels, which causes smooth-muscle relaxation (Usmani, Ito <em>et al.</em> 2005).</p>\n<p><strong>3.2 Specific immunotherapy for allergens</strong></p>\n<p>Allergen-specific immunotherapy (SIT) is an immune-modifying treatment that has been suggested for mild bronchial asthma, venom hypersensitivity, allergic rhinitis, and certain medication allergies. Repeated exposure to the allergen or allergens causes <a name=\"_Hlk186818114\"></a>SIT to produce blocking IgG4 antibodies and immunological tolerance. Following either natural or experimental exposure to allergens, SIT reduces the recruitment of mast cells, basophils, and eosinophils in the mucosa of the skin, nose, eyes, and bronchi (Figure.4). The level of IgA and IgG4 antibodies specific to allergens rises with SIT, but the level of IgE antibodies specific to allergens falls. Additionally, it stimulates CD4+CD25+FOXP3+ TReg cells that generate large amounts of TGF&beta; and/or IL-10, two cytokines known to reduce TH2-cell responses specific to allergens (Wu, Bi<em> et</em> <em>al.</em> 2007). A varied and self-tolerant T-cell repertoire, including TReg cells6, is maintained by the pleiotropic actions of TGF&beta;, while IL-10 inhibits mast-cell, eosinophil, and T-cell responses.</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p><strong>Figure.3. </strong>Immunological characteristics and the impact of allergen-specific immunotherapy (SIT). SIT alters humoral and cellular reactions to allergens. After SIT, functional regulatory T (TReg) cells are activated and the ratio of T helper 1 (TH1)-cell cytokines to TH2-cell cytokines increases. B cells, T cells, macrophages, and monocytes all produce more interleukin-10 (IL-10). Increased transforming growth factor-&beta; (TGF&beta;) production may help TReg-cell activity and immunoglobulin class-switching to IgA, IgG1, and IgG4 when combined with IL-10. These immunoglobulins reduce the amount of allergen capture and presentation that IgE facilitates when it forms a complex with either the low-affinity receptor for IgE (Fc&epsilon;RII, CD23) or the high-affinity receptor for IgE (Fc&epsilon;RI) by competing with IgE for allergen binding. Furthermore, SIT reduces both the quantity of mast cells and their capacity to release mediators. Additionally, fewer neutrophils and eosinophils are drawn to areas where allergens are present.</p>\n<p><strong>3.3 IgE as a Therapeutic target</strong></p>\n<p>Hannah Gould and Brian Sutton go over the sentinel function of IgE in boosting allergen absorption by DCs and triggering mast cells and basophils for mediator release in this issue. It has been demonstrated that IgG antibodies that target the C3 domain of IgE and prevent IgE from binding to Fc&epsilon;RI (as well as Fc&epsilon;RII, CD23) reduce allergen-induced inflammatory reactions in both humans and mice (Corne, Djukanovic <em>et al. </em>1997). A non-anaphylactic, humanized IgE-specific IgG1 called omalizumab has been created to treat severe allergic asthma (Figure.4). According to clinical trials conducted on adults, adolescents, and children with poorly controlled IgE-mediated asthma, omalizumab given subcutaneously two to four times a week (in proportion to the patient's body weight and the total amount of IgE in their serum) improves symptom control and enables patients to be treated with lower doses of inhaled corticosteroids. Up to 52 weeks of clinical trials have shown that omalizumab is well tolerated.</p>\n<p>The initial dose of omalizumab causes a sharp drop in the amount of circulating free IgE, but it takes up to 16 weeks of treatment before the best clinical results are observed. Treatment for allergic rhino conjunctivitis can also be achieved with omalizumab; however, it must start well in advance of the pollen season. The creation of an active immunization vaccine based on peptides to produce long-lasting, protective, IgE-specific antibodies is of interest. IgE peptide-based vaccinations can cause IgE-specific autoantibodies in sensitized rats (Plewako, Arvidsson <em>et al.</em> 2002).Phase II clinical trials for RP01, a new immunotherapeutic that stimulates the development of IgE-specific antibodies, have recently begun. In addition to lowering circulating IgE levels, lumiliximab, an antibody that targets the low-affinity IgE receptor Fc&epsilon;RII, has successfully completed Phase 1 studies for mild to moderate allergic asthma (Vernersson, Ledin <em>et al.</em> 2002).</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;<strong>Figure.4. The impact of IgE targeting on allergic reactions. </strong>In order to reduce allergic reactions, the monoclonal IgEspecific antibody omalizumab can lower free IgE levels and lessen IgE binding to both high-affinity (Fc&epsilon;RI) and low-affinity (Fc&epsilon;RII) IgE receptors. Omalizumab suppresses the production of Fc&epsilon;RI and prevents IgE from attaching to mast cells, basophils, and eosinophils. In order to stop IgE-dependent allergen presentation, this will also lessen the inflammatory response mediated by T helper cells.</p>\n<p><strong>3.4 Inhibitors of mast cells</strong></p>\n<p>First used to treat asthma in 1968, sodium chloroglicate (SCG) is the quintessential mast-cell-stabilizing medication. In 1984, nedocromil sodium was added to the list of medications. Following inhalation, both medications block the early- and late-phase reactions brought on by allergens in the conjunctiva, upper and lower airways, and mucosal mast cells, which play a critical role in the allergic response (Edwards and Howell 2000). Nedocromil sodium and SCG raise the threshold for activation99 by preventing the flow of chloride ions in mast cells, epithelial cells, neurons. A Ca2+-activated K+ channel, K(Ca)3.1, is also expressed by human mast cells and promotes mast-cell chemotaxis and increases IgE-dependent mast-cell activation. This suggests that blocking K(Ca)3.1 with medications like clotrimazole and TRAM-34 (1-[(2-chlorophenyl) diphenylmethyl]-1H-pyrazole) may be a novel method of inhibiting mast cells (Edwards and Howell 2000).</p>\n<p>The tetraspanin protein family member CD63 is another recently discovered cell-surface target on mast cells. CD63 alters adhesion to fibronectin and vitronectin by interacting with the &alpha;3, &alpha;4, and &alpha;6 chains of &beta;1 integrins and interfering with integrin signaling, localization, or trafficking. A monoclonal antibody that suppresses CD63 prevents extracellular matrix protein-adherent mast cells from being activated by Fc&epsilon;RI, but not nonadherent cells (Kraft, Fleming <em>et al.</em> 2005). The biochemical events that are started by the binding of Fc&epsilon;RI103 are significantly modulated by the SRC tyrosine kinases FYN and LYN. Inactivating the SYK that promotes Fc&epsilon;RI signaling104 is a unique method of preventing mast-cell activation. A reversible mast-cell SYK inhibitor105 was identified as 2,4-diaminopyrimidine (R112) via a cell-based, high-throughput screen for small compounds that block IgE signaling. In allergic rhinitis, intranasal R112 treatment followed by allergen exposure prevented rhinorrhea and nasal blockage in addition to inhibiting the formation of prostaglandin D2 (Meltzer, Berkowitz <em>et al. </em>2005).</p>\n<p>For mast cell growth, proliferation, survival, homing, and adhesion, as well as for the best possible IgE-induced mast-cell degranulation and cytokine release, stem-cell factor (SCF) must interact with its tyrosine-kinase receptor KIT. SCF-specific antibodies, antisense oligonucleotides, KIT inhibitors, and inhibitors of downstream signaling pathways are examples of potential medications that target SCF or KIT.</p>\n<p><strong>3.5 Cytokine-based immunotherapies</strong></p>\n<p>TH2 cytokines and their receptors are important therapeutic targets due to their sentinel function in coordinating allergic inflammation (Figure.5). This strategy has nearly always involved the use of biological agents, such as fusion proteins, blocking monoclonal antibodies, and, most recently, inhibitors of the TH2-cell transcription factors GATA3 and STAT6 (signal transducer and activator of transcription 6).</p>\n<p><strong>IL-4</strong> In order for B cells to manufacture IgE, they must switch their immunoglobulin isotype, and IL-4 by itself is essential for preserving the TH2-cell phenotype. For these reasons, both cytokines are promising targets for therapy. Many investigations on animals have demonstrated that preventing the generation of IL-4 or reducing its effects has a significant impact on the allergy phenotype. It is a non-immunogenic soluble, recombinant human IL-4 receptor (altrakincept) made up of the extracellular part of human IL-4R&alpha;. Nebulized inhalation altrakincept was shown to be effective in a 12-week proof of concept trial in patients with mild to moderate asthma by permitting cessation of inhaled corticosteroid medication without recurrence. This finding was then verified in a larger trial (Borish, Nelson <em>et al. </em>2001).</p>\n<p>However, the effectiveness of altrakincept in treating asthma was not confirmed by a Phase III trial. Although there were issues with the bioavailability of altrakincept in this investigation, this trial does not rule out IL-4 as a target for the treatment of allergies and asthma. Additional Phase II humanized IL-4-specific and IL-4R&alpha;-blocking antibodies, as pascolizumab (SB240,683)120, are being used in ongoing research. Two IL-4 vaccines have been tested in mice: one involves chemically coupling IL-4 to limpet haemocyanin121, and the other involves inserting a 14-amino acid peptide from IL-4 into the core antigen of the varian hepatitis B virus. (Linhart, Bigenzahn <em>et al. </em>2007)Both vaccinations prevented lung inflammation brought on by antigens and produced significant antibody titres specific for mouse IL-4. However, it was discovered that the secondary IgE response is not T-cell dependent when co-stimulation blocking was used in a rat model of grass pollen allergy. This raises questions about the efficacy of IL-4 blockade in treating established allergic illness.</p>\n<p><strong>IL-13.</strong> IL-13 is an important therapeutic target in allergy and asthma because of its many roles in controlling IgE production, eosinophilic inflammation, airway smooth-muscle hyperplasia, inducing goblet-cell hyperplasia with mucus production, and attracting monocytes, macrophages, and T cells into the airway spaces124. Both a low-affinity IL\u201113R&alpha;1 subunit and a high-affinity complex made up of IL\u2011 and IL\u20114R&alpha; are bound by IL\u201113. When this high-affinity complex is bound, Janus kinase 1 (JAK1), JAK2, and STAT6 are activated phosphorylation-dependently. Additionally, IL-4R&alpha; enhances IL-13-mediated responses by stabilizing IL-13's binding to its receptor. Nevertheless, the action of IL-13 is strongly inhibited by IL-13R&alpha;2, a non-signalling, high-affinity IL-13-binding chain. A soluble version of IL-13R&alpha;2, which competes for binding to IL-13 but not to IL-4, has been used to selectively inhibit IL-13 in mice. This has caused the formation of mucus and a reversal of airway hyperresponsiveness in mice that have been sensitized to allergens. Serum from mice but not from humans has a soluble version of IL-13R&alpha;2, which binds IL-13 with an affinity 100 times higher than that of IL-13R&alpha;1 (Andrews, Nasir <em>et al.</em> 2006).</p>\n<p><strong>IL-5. </strong>Numerous models of asthma have shown that IL-5 plays a significant role, according to research on rodents and nonhuman primates. For people with asthma, inhaled IL-5 reduces the quantity of eosinophil progenitors in their airways and bone marrow, but for people without asthma, it causes localized eosinophilia. To treat asthma, two humanized, human IL-5-specific monoclonal antibodies have been created: mepolizumab (SB-240,563) and Sch-55,700. Surprisingly, mepolizumab had no effect on the late asthmatic response or airway hyperresponsiveness despite producing a rapid dose-dependent drop in circulating and sputum eosinophil counts that lasted for three months in a small, double-blind experiment (Leckie, ten Brinke <em>et al. </em>2000). Sch-55,700 treatment reduced blood eosinophil counts in a group of patients with severe persistent asthma, but it had no effect on any asthma outcome measures over a 10-week period134. This finding was recently supported by a sizable trial using mepolizumab.</p>\n<p><strong>IL-9. </strong>In animal models, IL-9 blockade decreases allergen-induced airway inflammation and airway hyperresponsiveness. An IL-9-specific monoclonal antibody has undergone two successful Phase I dose-escalation trials in healthy volunteers. There are currently phase II trials underway to treat persistent, moderate-to-severe asthma symptoms (O'Byrne, Boulet <em>et al. </em>2007).</p>\n<p><strong>IL-12. </strong>A potent signal from IL-12 directs naive precursor T cells to differentiate into TH1 cells both in vitro and in vivo, changing the immune response to cell-mediated immunity. In animal models, IL-12 administered during sensitization decreases airway hyperresponsiveness and airway eosinophilia following antigen challenge, as well as allergen-induced TH2-cell responses in favor of TH1-cell growth. Whole blood cell synthesis of IL-12 and airway biopsies expression of it are both compromised in asthma. Thus, IL-12 has the capacity to alter allergy conditions. Patients with mild asthma who received injections of recombinant human IL-12 experienced flu-like symptoms, abnormal liver-function tests, and cardiac arrhythmias in addition to a decrease in circulating blood eosinophils following allergen challenge (but not sputum eosinophilia, the late-phase response, or airway hyperresponsiveness) (Kuipers, Heirman <em>et al. </em>2004). The finding that DCs retrovirally overexpressing IL-12 in mice produce robust TH1-cell responses to inhaled antigen in the lung but are unable to inhibit TH2-cell polarization following sensitization calls into question this strategy as well.</p>\n<p><strong>IL-10. </strong>IL-10 is the primary inhibitory cytokine generated by TReg cells in allergen immunotherapy, and it suppresses the expression of numerous proinflammatory cytokines, chemokines, and pro-inflammatory enzymes. After allergen challenge, IL-10-deficient animals exhibit elevated airway inflammation; in outbred mice, this was prevented by intratracheal delivery of the IL-10 gene. IL-10 administration to healthy individuals reduces the quantity of CD4+ and CD8+ T cells in circulation while suppressing endotoxin-driven TNF and IL-1&beta; production and mitogen-induced T-cell proliferation (Fu, Chuang <em>et al. </em>2006).</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p><strong>Figure.5. Cytokine-based therapies in asthma. </strong>Since allergic inflammation is primarily a T helper 2 (TH2)-cell disease, there has been a strong push to change the TH2-&ndash;TH1-cell balance in asthma. This has been accomplished either by enhancing TH1-cell responses (interferon-&gamma; (IFN&gamma;) and IL-12) or by blocking TH2-cell cytokines (particularly interleukin-4 (IL-4), IL-13, and IL-5). IgE-specific monoclonal antibodies can also be used to inhibit the allergic component of atopic asthma. TCR stands for T-cell receptor; rh stands for recombinant human; FceRI for high-affinity receptor for IgE; and APC for antigen-presenting cell.</p>\n<p>&nbsp;</p>\n<p><strong>&nbsp;</strong></p>\n<p><strong>&nbsp;</strong></p>\n<p><strong>&nbsp;</strong></p>\n<p><strong>Conclusions</strong></p>\n<p>Asthma and other allergy illnesses have become much more common in recent decades, impacting an estimated 20% of the population in affluent nations. Recent discoveries about the pathophysiology of allergies and asthma as well as the molecular mechanism behind the activation of important target cells present therapeutic opportunities. In addition to being useful in treating asthma, anti-IgE therapy may also be useful in treating other allergic conditions like rhinitis and food allergies. There are currently compounds in clinical development that block mast cell activation at the receptor or intracellular level, and methods to counteract pro-inflammatory mediators like TNF-&alpha; have showed promise in treating individuals with severe asthma. Allergen-specific immunotherapy (SIT ) to produce blocking IgG4 antibodies and immunological tolerance.</p>\n<p>&nbsp;</p>\n<p><strong>&nbsp;</strong></p>\n<p><strong>References</strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>",
        "access_right": "open",
        "creators": [
          {
            "name": "Hussain, Zahid",
            "affiliation": "Government College University, Lahore",
            "orcid": "0000-0002-7554-8957"
          }
        ],
        "contributors": [
          {
            "name": "Sehra",
            "affiliation": "Government College University, Lahore",
            "type": "Researcher"
          }
        ],
        "keywords": [
          "Therapy",
          "asthma",
          "Hypersensitivity",
          "Responses"
        ],
        "references": [
          "1.\u00a0\u00a0\u00a0\u00a0\u00a0 Andrews, A.-L., et al. (2006). \"IL-13 receptor \u03b1 2: A regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts.\" Journal of allergy and clinical immunology 118(4): 858-865.  2.\u00a0\u00a0\u00a0\u00a0\u00a0 Barnes, P. J. and I. Adcock (1998). \"Transcription factors and asthma.\" European Respiratory Journal 12(1): 221-234.  3.\u00a0\u00a0\u00a0\u00a0\u00a0 Barnes, P. J. and I. M. Adcock (2003). \"How do corticosteroids work in asthma?\" Annals of internal medicine 139(5_Part_1): 359-370.  4.\u00a0\u00a0\u00a0\u00a0\u00a0 Barnes, P. J., et al. (1998). \"Inflammatory mediators of asthma: an update.\" Pharmacological reviews 50(4): 515-596.  5.\u00a0\u00a0\u00a0\u00a0\u00a0 Bogaert, P., et al. (2009). \"Where asthma and hypersensitivity pneumonitis meet and differ: noneosinophilic severe asthma.\" The American journal of pathology 174(1): 3-13.  6.\u00a0\u00a0\u00a0\u00a0\u00a0 Borish, L. C., et al. (2001). \"Efficacy of soluble IL-4 receptor for the treatment of adults with asthma.\" Journal of allergy and clinical immunology 107(6): 963-970.  7.\u00a0\u00a0\u00a0\u00a0\u00a0 Corne, J., et al. (1997). \"The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics.\" The Journal of clinical investigation 99(5): 879-887.  8.\u00a0\u00a0\u00a0\u00a0\u00a0 Eder, W., et al. (2006). \"The asthma epidemic.\" New England Journal of Medicine 355(21): 2226-2235.  9.\u00a0\u00a0\u00a0\u00a0\u00a0 Edwards, A. and J. Howell (2000). \"The chromones: history, chemistry and clinical development. A tribute to the work of Dr REC Altounyan.\" Clinical and Experimental Allergy 30(6): 756-774.  10.\u00a0 Fu, C. L., et al. (2006). \"Effects of adenovirus\u2010expressing IL\u201010 in alleviating airway inflammation in asthma.\" The Journal of Gene Medicine: A cross\u2010disciplinary journal for research on the science of gene transfer and its clinical applications 8(12): 1393-1399.  11.\u00a0 Hammad, H. and B. N. Lambrecht (2006). \"Recent progress in the biology of airway dendritic cells and implications for understanding the regulation of asthmatic inflammation.\" Journal of Allergy and Clinical Immunology 118(2): 331-336.  12.\u00a0 Kraft, S., et al. (2005). \"Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo.\" The Journal of experimental medicine 201(3): 385-396.  13.\u00a0 Kuipers, H., et al. (2004). \"Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization.\" Journal of leukocyte biology 76(5): 1028-1038.  14.\u00a0 Leckie, M. J., et al. (2000). \"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.\" The Lancet 356(9248): 2144-2148.  15.\u00a0 Linhart, B., et al. (2007). \"Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy.\" The Journal of Immunology 178(6): 3924-3931.  16.\u00a0 Meltzer, E. O., et al. (2005). \"An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment.\" Journal of allergy and clinical immunology 115(4): 791-796.  17.\u00a0 O'Byrne, P., et al. (2007). \"A single dose of MEDI-528, a monoclonal antibody against interleukin-9, is well tolerated in mild and moderate asthmatics in the phase II trial MI-CP-138.\" Chest 132(4): 478A.  18.\u00a0 Palmqvist, M., et al. (1997). \"Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency.\" European Respiratory Journal 10(11): 2484-2489.  19.\u00a0 Plewako, H., et al. (2002). \"The effect of omalizumab on nasal allergic inflammation.\" Journal of allergy and clinical immunology 110(1): 68-71.  20.\u00a0 Romagnani, S. (2000). \"The role of lymphocytes in allergic disease.\" Journal of Allergy and Clinical Immunology 105(3): 399-408.  21.\u00a0 Sampson, H. A. (2004). \"Update on food allergy.\" Journal of Allergy and Clinical Immunology 113(5): 805-819.  22.\u00a0 Strachan, D. P. (1989). \"Hay fever, hygiene, and household size.\" BMJ: British Medical Journal 299(6710): 1259.  23.\u00a0 Usmani, O. S., et al. (2005). \"Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy.\" American journal of respiratory and critical care medicine 172(6): 704-712.  24.\u00a0 Vernersson, M., et al. (2002). \"Generation of therapeutic antibody responses against IgE through vaccination.\" The FASEB Journal 16(8): 875-877.  25.\u00a0 von Garnier, C., et al. (2007). \"Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa.\" The Journal of Immunology 179(9): 5748-5759.  26.\u00a0 Wu, K., et al. (2007). \"IL-10-producing type 1 regulatory T cells and allergy.\" Cell Mol Immunol 4(4): 269-275."
        ],
        "language": "eng",
        "resource_type": {
          "title": "Preprint",
          "type": "publication",
          "subtype": "preprint"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "14948533"
              }
            }
          ]
        }
      },
      "title": "Therapy of asthma and Hypersensitivity Responses",
      "links": {
        "self": "https://zenodo.org/api/records/14948534",
        "self_html": "https://zenodo.org/records/14948534",
        "doi": "https://doi.org/10.5281/zenodo.14948534",
        "self_doi": "https://doi.org/10.5281/zenodo.14948534",
        "self_doi_html": "https://zenodo.org/doi/10.5281/zenodo.14948534",
        "parent": "https://zenodo.org/api/records/14948533",
        "parent_html": "https://zenodo.org/records/14948533",
        "parent_doi": "https://doi.org/10.5281/zenodo.14948533",
        "parent_doi_html": "https://zenodo.org/doi/10.5281/zenodo.14948533",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:14948534/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:14948534/sequence/default",
        "files": "https://zenodo.org/api/records/14948534/files",
        "media_files": "https://zenodo.org/api/records/14948534/media-files",
        "archive": "https://zenodo.org/api/records/14948534/files-archive",
        "archive_media": "https://zenodo.org/api/records/14948534/media-files-archive",
        "latest": "https://zenodo.org/api/records/14948534/versions/latest",
        "latest_html": "https://zenodo.org/records/14948534/latest",
        "versions": "https://zenodo.org/api/records/14948534/versions",
        "draft": "https://zenodo.org/api/records/14948534/draft",
        "reserve_doi": "https://zenodo.org/api/records/14948534/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/14948534/access/links",
        "access_grants": "https://zenodo.org/api/records/14948534/access/grants",
        "access_users": "https://zenodo.org/api/records/14948534/access/users",
        "access_request": "https://zenodo.org/api/records/14948534/access/request",
        "access": "https://zenodo.org/api/records/14948534/access",
        "communities": "https://zenodo.org/api/records/14948534/communities",
        "communities-suggestions": "https://zenodo.org/api/records/14948534/communities-suggestions",
        "requests": "https://zenodo.org/api/records/14948534/requests"
      },
      "updated": "2025-03-01T09:17:45.545443+00:00",
      "recid": "14948534",
      "revision": 6,
      "files": [
        {
          "id": "da2c5a17-597c-4ac2-8f33-c9f5e5f52970",
          "key": "Therapy of asthma and hypersentivity response.docx",
          "size": 310109,
          "checksum": "md5:13f2b6ca4fba47082cc82987508b42e8",
          "links": {
            "self": "https://zenodo.org/api/records/14948534/files/Therapy of asthma and hypersentivity response.docx/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "1236103"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 2,
        "unique_downloads": 2,
        "views": 4,
        "unique_views": 4,
        "version_downloads": 2,
        "version_unique_downloads": 2,
        "version_unique_views": 4,
        "version_views": 4
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-02-22T08:31:25.924788+00:00",
      "modified": "2025-02-22T08:31:26.127244+00:00",
      "id": 14909279,
      "conceptrecid": "14909278",
      "doi": "10.3897/pharmacia.72.e146759",
      "doi_url": "https://doi.org/10.3897/pharmacia.72.e146759",
      "metadata": {
        "title": "The role of the transcription factor NF-kB in the pathogenesis of inflammation and carcinogenesis. Modulation capabilities",
        "doi": "10.3897/pharmacia.72.e146759",
        "publication_date": "2025-02-20",
        "description": "<p>The nuclear factor kappa B (NF-kB) signaling module is a complex and highly interconnected molecular network with important functions in all nucleated cells. Most chronic diseases caused by lifestyle factors appear to be related to inflammation. The NF-kB plays a major role in the pathogenesis of the inflammation and its intimate molecular mechanism. This transcription factor participates in the evolution of diabetes and its complications. In T1D (Type 1 Diabetes), proinflammatory cytokines such as interleukin-1\u03b2 (IL-1\u03b2), tumor necrosis factor (TNF), and CD40L secreted by immune cells in islets induce the activation of NF-kB in \u03b2-cells through both canonical and noncanonical roads. NF-kB activation increases the expression of genes, including TNF-\u03b1, IL-1\u03b2, IL-6, MCP-1, and ICAM-1, that initiate and promote atherosclerosis. In particular, the severity and lethality of acute lung injury or acute respiratory distress syndrome (ALI/ARDS) caused by pneumonia or sepsis is primarily associated with an NF-kB-mediated \"cytokine storm,\" in which massive polymorphonuclear (PMN) extravasation and the subsequent release of cytokines cause rapid deterioration due to widespread inflammation and coagulation. Nuclear translocation of NF-kB p65 can induce the transcription of several genes involved in the induction of EMT (epithelial-to-mesenchymal transition). This has been confirmed in various types of cancer, including brain, breast, lung, and gastric cancer. Cutaneous T-cell lymphoma (CTCL) encompasses a group of lymphoproliferative disorders characterized by invasive neoplastic T cells in the skin and various clinical prognoses. In the early stages of CTCL, NF-kB activation and cell proliferation are stimulated by the autocrine production of TNF\u03b1, leading to increased NF-kB activation and resistance to apoptosis. Bladder cancer is the second most common genitourinary cancer and is often recurrent and/or chemoresistant after tumor resection. NF-kB is a transcription factor that plays a critical role in normal physiology and bladder cancer. Bladder cancer patients have pathologically active NF-kB induced by proinflammatory cytokines, chemokines, and hypoxia, enhancing carcinogenesis and progression of the disease.</p>",
        "access_right": "open",
        "creators": [
          {
            "name": "Moneva-Sakelarieva, Maria",
            "affiliation": "Clinic of Internal Diseases UMHATEM \"N. I. Pirogov\", Sofia, Bulgaria|Medical University - Sofia, Sofia, Bulgaria"
          },
          {
            "name": "Kobakova, Yozlem",
            "affiliation": "Clinic of Internal Diseases UMHATEM \"N. I. Pirogov\", Sofia, Bulgaria|Medical University - Sofia, Sofia, Bulgaria"
          },
          {
            "name": "Konstantinov, Spiro",
            "affiliation": "Medical University - Sofia, Sofia, Bulgaria"
          },
          {
            "name": "Momekov, Georgi",
            "affiliation": "Medical University - Sofia, Sofia, Bulgaria"
          },
          {
            "name": "Ivanova, Stefka",
            "affiliation": "Bulgarian Pharmaceutical Science Society, Sofia, Bulgaria"
          },
          {
            "name": "Atanasova, Ventseslava",
            "affiliation": "Bulgarian Pharmaceutical Union, Sofia, Bulgaria"
          },
          {
            "name": "Chaneva, Maria",
            "affiliation": "Clinic of Internal Diseases UMHATEM \"N. I. Pirogov\", Sofia, Bulgaria"
          },
          {
            "name": "Tododrov, Radoslav",
            "affiliation": "Clinic of Internal Diseases UMHATEM \"N. I. Pirogov\", Sofia, Bulgaria"
          },
          {
            "name": "Bashev, Nikolay",
            "affiliation": "Clinic of Internal Diseases UMHATEM \"N. I. Pirogov\", Sofia, Bulgaria"
          },
          {
            "name": "Atanasov, Petar",
            "affiliation": "Clinic of Internal Diseases UMHATEM \"N. I. Pirogov\", Sofia, Bulgaria"
          }
        ],
        "keywords": [
          "transcription factor NF-kB",
          "inflammation",
          "chronic diseases",
          "breast cancer",
          "T-cell cutaneous lymphoma",
          "urothelial carcinoma"
        ],
        "related_identifiers": [
          {
            "identifier": "10.3897/pharmacia.72.e146759.figure1",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.3897/pharmacia.72.e146759.figure2",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.cbi.2021.109450",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.arcmed.2010.03.005",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1007/s10753-016-0413-4",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1007/s10787-018-0458-0",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1371/journal.pcbi.1011065",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1371/journal.pone.0023999",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.breast.2022.08.010",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1126/science.270.5234.286",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3390/biology8020037",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3389/fimmu.2021.716469",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1182/blood-2004-06-2181",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1172/JCI118598",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/jid.2011.316",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1172/JCI63528",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1096/fj.202002742RR",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1073/pnas.1322269111",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/s41598-020-62136-2",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3892/mmr.2017.8300",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.18632/Oncotarget23208",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3389/fimmu.2021.589095",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1126/science.abc0269",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.cbi.2022.110295",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1007/s00281-017-0639-8",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/S0140-6736(22)00470-6",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/s41569-020-0406-8",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3389/fimmu.2023.1129191",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1128/JVI.02576-13",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.giec.2019.02.006",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1111/j.1600-065X.2012.01099.x",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/nrendo.2009.21",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1056/NEJMra2026131",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3389/fimmu.2020.583687",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.dld.2012.11.010",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.2174/1389450119666180219120534",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.giec.2019.02.005",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.jdiacomp.2017.09.010",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/s0092-8674(02)00703-1",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.2147/JIR.S140188",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3390/biomedicines6020038",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1007/s10787-020-00773-9",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/cr.2011.13",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1101/gad.183434.111",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1161/CIR.0000000000001063",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1161/01.ATV.0000201938.78044.75",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1096/fj.01-0707fje",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1513/pats.200806-054RM",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3980/j.issn.2222-3959.2015.03.03",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3390/cells10082042",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1158/0008-5472.CAN-18-1825",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.molmed.2007.09.002",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.kint.2021.04.036",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.celrep.2017.03.027",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.ejca.2012.06.003",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1111/j.2040-1124.2010.00018.x",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/s41418-023-01112-5",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.intimp.2015.01.004",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.jep.2023.117497",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3109/08830185.2010.529976",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1615/CritRevImmunol.2020033210",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1155/2011/282356",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.autrev.2020.102469",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1155/2021/9944880",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.lfs.2019.117146",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.phymed.2022.154627",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/sigtrans.2017.23",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.2147/COPD.S449521",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.jnutbio.2016.12.004",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3389/fcell.2020.606123",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.bbrc.2009.01.092",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1513/pats.200905-027DS",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.15420/ecr.2023.10",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.5334/gh.1156",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1590/1678-775720130593",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1530/JME-16-0183",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3390/ijms20092322",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1002/jcp.30759",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1093/carcin/bgu321",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1167/iovs.06-1473",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/nrc1588",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1158/1535-7163.MCT-13-0464",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1056/NEJMoa2021372",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/S0140-6736(98)09286-1",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1101/cshperspect.a000034",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/ni.2065",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/s1734-1140(09)70111-2",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.biopha.2023.114822",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1007/s13679-014-0124-9",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.cll.2017.06.006",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3892/mmr.2012.1054",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.bbrc.2007.01.003",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/s41598-023-28261-4",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.biopha.2020.110569",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1056/NEJMoa2021436",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1056/NEJMoa1707914",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1515/JPM.2008.065",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.bbagen.2007.04.011",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.jbc.2022.101695",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/0092-8674(86)90346-6",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1146/annurev-immunol-101320-031555",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1158/1078-0432.CCR-07-1419",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/sj.onc.1206486",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.preteyeres.2011.05.002",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1007/s11356-019-05194-y",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1093/annonc/mdn056",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1089/jir.2018.0060",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1080/14737159.2020.1743688",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.2337/db09-1420",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/s41417-023-00716-w",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.ophtha.2016.10.031",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.ejps.2020.105302",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1371/journal.pone.0091111",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3389/fphar.2021.706908",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1084/jem.20071393",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1503/CMAJ200645",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.3390/cancers14215215",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1002/cbf.4030",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1038/jid.2010.86",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.cell.2016.12.012",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1016/j.lfs.2019.05.020",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          },
          {
            "identifier": "10.1200/JCO.2007.11.4207",
            "relation": "cites",
            "resource_type": "publication",
            "scheme": "doi"
          }
        ],
        "references": [
          "Abdin SM, Tolba MF, Zaher DM, Omar HA (2021) Nuclear factor-\u03baB signaling inhibitors revert multidrug-resistance in breast cancer cells. Chemico-Biological Interactions 340: 109450. https://doi.org/10.1016/j.cbi.2021.109450",
          "Ahirwar DK, Mandhani A, Mittal RD (2010) IL-8 -251 T > A polymorphism is associated with bladder cancer susceptibility and outcome after BCG immunotherapy in a northern Indian cohort. Archives of Medical Research 41(2): 97\u2013103. https://doi.org/10.1016/j.arcmed.2010.03.005",
          "Ahmed S, Mundhe N, Borgohain M, Chowdhury L, Kwatra M, Bolshette N, Ahmed A, Lahkar M (2016) Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan- Induced Diabetic Nephropathy. Inflammation 39(5): 1783\u20131797. https://doi.org/10.1007/s10753-016-0413-4",
          "Akbari M, Hassan-Zadeh V (2018) IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology 26(3): 685\u2013698. https://doi.org/10.1007/s10787-018-0458-0",
          "Amstein LK, Ackermann J, Hannig J, \u0110iki\u0107 I, Fulda S, Koch I (2022) Mathematical modeling of the molecular switch of TNFR1-mediated signaling pathways applying Petri net formalism and in silico knockout analysis [published correction appears in PLoS Computational Biology 2023 Apr 14;19(4): e1011065. https://doi.org/10.1371/journal.pcbi.1011065]. PLoS Computational Biology 18(8): e1010383. [Published 2022 Aug 22] https://doi.org/10.1371/journal.pcbi.1010383",
          "Andreasen AS, Kelly M, Berg RM, M\u00f8ller K, Pedersen BK (2011) Type 2 diabetes is associated with altered NF-\u03baB DNA binding activity, JNK phosphorylation, and AMPK phosphorylation in skeletal muscle after LPS. PLoS ONE 6(9): e23999. https://doi.org/10.1371/journal.pone.0023999",
          "Arnold M, Morgan E, Rumgay H, Mafraa A, Singha D, Laversannea M, Vignata J, Gralowb JR, Cardosoc F, Sieslingd S, Soerjomatarama I (2022) Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast 66: 15\u201323. https://doi.org/10.1016/j.breast.2022.08.010",
          "Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270(5234): 286\u2013290. https://doi.org/10.1126/science.270.5234.286",
          "Barcelos IP, Troxell RM, Graves JS (2019) Mitochondrial Dysfunction and Multiple Sclerosis. Biology (Basel) 8(2): 37. [Published 2019 May 11] https://doi.org/10.3390/biology8020037",
          "Barnabei L, Laplantine E, Mbongo W, Rieux-Laucat F, Weil R (2021) NF-\u03baB: At the Borders of Autoimmunity and Inflammation. Frontiers in Immunology 12: 716469. [Published 2021 Aug 9] https://doi.org/10.3389/fimmu.2021.716469",
          "Berger CL, Tigelaar R, Cohen J, Mariwalla K, Trinh J, Wang N, Edelson RL (2005) Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 105(4): 1640\u20131647. https://doi.org/10.1182/blood-2004-06-2181",
          "Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D (1996) Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. Journal of Clinical Investigation 97(7): 1715\u20131722. https://doi.org/10.1172/JCI118598",
          "Braun FK, Al-Yacoub N, Pl\u00f6tz M, M\u00f6bs M, Sterry W, Eberle J (2012) Nonsteroidal anti- inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand. Journal of Investigative Dermatology 132(2): 429\u2013439. https://doi.org/10.1038/jid.2011.316",
          "Br\u00fcstle A, Brenner D, Knobbe CB, Lang PA, Virtanen C, Hershenfield BM, Reardon C, Lacher SM, Ruland J, Ohashi PS, Mak TW (2012) The NF-\u03baB regulator MALT1 determines the encephalitogenic potential of Th17 cells. Journal of Clinical Investigation 122(12): 4698\u20134709. https://doi.org/10.1172/JCI63528",
          "Cao X, Tian Y, Nguyen V, Zhang Y, Gao C, Yin R, Carver W, Fan D, Albrecht H, Cui T, Tan W (2021) Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice. The FASEB Journal 35(9): e21801. https://doi.org/10.1096/fj.202002742RR",
          "Chang PV, Hao L, Offermanns S, Medzhitov R (2014) The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. National Academy of Sciences of the United States of America 111(6): 2247\u20132252. https://doi.org/10.1073/pnas.1322269111",
          "Chen BH, Hsieh CH, Tsai SY, Wang CY, Wang CC (2020) Anticancer effects of epigallocatechin- 3-gallate nanoemulsion on lung cancer cells through the activation of AMP-activated protein kinase signaling pathway. Scientific Reports 10(1): 5163. [Published 2020 Mar 20] https://doi.org/10.1038/s41598-020-62136-2",
          "Chen J, Cao X, Cui Y, Zeng G, Chen J, Zhang G (2018) Resveratrol alleviates lysophosphatidylcholine-induced damage and inflammation in vascular endothelial cells. Molecular Medicine Reports 17(3): 4011\u20134018. https://doi.org/10.3892/mmr.2017.8300",
          "Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L (2017) Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9(6): 7204\u20137218. [Published 2017 Dec 14] https://doi.org/10.18632/Oncotarget23208",
          "Chen R, Lan Z, Ye J, Pang L, Liu Y, Wu W, Qin X, Guo Y, Zhang P (2021) Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration. Frontiers in Immunology 12: 589095. [Published 2021 Apr 28] https://doi.org/10.3389/fimmu.2021.589095",
          "Cheng QJ, Ohta S, Sheu KM et al. (2021) NF-\u03baB dynamics determine the stimulus specificity of epigenomic reprogramming in macrophages. Science 372(6548): 1349\u20131353. https://doi.org/10.1126/science.abc0269",
          "Cheng X, Wang F, Qiao Y, Chen T, Fan L, Shen X, Yu D, Huang Y, Wei M (2023) Honokiol inhibits interleukin-induced angiogenesis in the NSCLC microenvironment through the NF-\u03baB signaling pathway. Chemico-Biological Interactions 370: 110295. https://doi.org/10.1016/j.cbi.2022.110295",
          "Chousterman BG, Swirski FK, Weber GF (2017) Cytokine storm and sepsis disease pathogenesis. Seminars in Immunopathology 39(5): 517\u2013528. https://doi.org/10.1007/s00281-017-0639-8",
          "Christenson SA, Smith BM, Bafadhel M, Putcha N (2022) Chronic obstructive pulmonary disease. The Lancet 399(10342): 2227\u20132242. https://doi.org/10.1016/S0140-6736(22)00470-6",
          "Cowie MR, Fisher M (2020) SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control. Nature Reviews Cardiology 17(12): 761\u2013772. https://doi.org/10.1038/s41569-020-0406-8",
          "Daniels MA, Luera D, Teixeiro E (2023) NF\u03baB signaling in T cell memory. Frontiers in Immunology 14: 1129191. [Published 2023 Feb 24] https://doi.org/10.3389/fimmu.2023.1129191",
          "DeDiego ML, Nieto-Torres JL, Regla-Nava JA, Jimenez-Guarde\u00f1o JM, Fernandez-Delgado R, Fett C, Casta\u00f1o-Rodriguez C, Perlman S, Enjuanes L (2014) Inhibition of NF-\u03baB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. Journal of Virology 88(2): 913\u2013924. https://doi.org/10.1128/JVI.02576-13",
          "Deepak P, Axelrad JE, Ananthakrishnan AN (2019) The Role of the Radiologist in Determining Disease Severity in Inflammatory Bowel Diseases. Gastrointestinal Endoscopy Clinics of North America 29(3): 447\u2013470. https://doi.org/10.1016/j.giec.2019.02.006",
          "DiDonato JA, Mercurio F, Karin M (2012) NF-\u03baB and the link between inflammation and cancer. Immunological Reviews 246(1): 379\u2013400. https://doi.org/10.1111/j.1600-065X.2012.01099.x",
          "Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nature Reviews Endocrinology 5(4): 219\u2013226. https://doi.org/10.1038/nrendo.2009.21",
          "Ettari R, Previti S, Bitto A, Grasso S, Zappal\u00e0 M (2016) Immunoproteasome-Selective Inhibitors: A Promising Strategy to Treat Hematologic Malignancies, Autoimmune and Inflammatory Diseases. Current Medicinal Chemistry 23(12): 1217\u20131238.",
          "Fajgenbaum DC, June CH (2020) Cytokine Storm. The New England Journal of Medicine 383(23): 2255\u20132273. https://doi.org/10.1056/NEJMra2026131",
          "Forrester JV, Kuffova L, Delibegovic M (2020) The Role of Inflammation in Diabetic Retinopathy. Frontiers in Immunology 11: 583687. [Published 2020 Nov 6] https://doi.org/10.3389/fimmu.2020.583687",
          "Frasinariu OE, Ceccarelli S, Alisi A, Moraru E, Nobili V (2013) Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies. Digestive and Liver Disease 45(7): 543\u2013551. https://doi.org/10.1016/j.dld.2012.11.010",
          "Freitas RHCN, Fraga CAM (2018) NF-\u03baB-IKK\u03b2 Pathway as a Target for Drug Development: Realities, Challenges and Perspectives. Current Drug Targets 19(16): 1933\u20131942. https://doi.org/10.2174/1389450119666180219120534",
          "Fritsch J, Abreu MT (2019) The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg? Gastrointestinal Endoscopy Clinics of North America 29(3): 381\u2013393. https://doi.org/10.1016/j.giec.2019.02.005",
          "Gedebjerg A, Almdal TP, Berencsi K, Rungby J, Nielsen JS, Witte DR, Friborg S, Brandslund I, Vaag A, Beck-Nielsen H, H S\u00f8rensen T, Thomsen RW (2018) Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort. Journal of Diabetes and its Complications 32(1): 34\u201340. https://doi.org/10.1016/j.jdiacomp.2017.09.010",
          "Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109: S81\u2013S96. https://doi.org/10.1016/s0092-8674(02)00703-1",
          "Giridharan S, Srinivasan M (2018) Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation. Journal of Inflammation Research 11: 407\u2013419. [Published 2018 Oct 30] https://doi.org/10.2147/JIR.S140188",
          "Grondona P, Bucher P, Schulze-Osthoff K, Hailfinger S, Schmitt A (2018) NF-\u03baB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy. Biomedicines 6(2): 38. [Published 2018 Mar 26] https://doi.org/10.3390/biomedicines6020038",
          "Hangai M, Yoshimura N, Yoshida M, Yabuuchi K, Honda Y (1995) Interleukin-1 gene expression in transient retinal ischemia in the rat. Investigative Ophthalmology & Visual Science 36(3): 571\u2013578.",
          "Hariharan A, Hakeem AR, Radhakrishnan S, Reddy MS, Rela M (2021) The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients. Inflammopharmacology 29(1): 91\u2013100. https://doi.org/10.1007/s10787-020-00773-9",
          "Hayden MS, Ghosh S (2011) NF-\u03baB in immunobiology. Cell Research 21(2): 223\u2013244. https://doi.org/10.1038/cr.2011.13",
          "Hayden MS, Ghosh S (2012) NF-\u03baB, the first quarter-century: remarkable progress and outstanding questions. Genes & Development 26(3): 203\u2013234. https://doi.org/10.1101/gad.183434.111",
          "Heidenreich PA, Bozkurt B, Aguilar D et al. (2022) AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation. 2022 May 3;145(18): e1033.] [published correction appears in Circulation. 2022 Sep 27;146(13): e185.] [published correction appears in Circulation. 2023 Apr 4;147(14): e674.]. Circulation 145(18): e895\u2013e1032. https://doi.org/10.1161/CIR.0000000000001063",
          "Isoda K, Young JL, Zirlik A et al. (2006) Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arteriosclerosis, Thrombosis, and Vascular Biology 26(3): 611\u2013617. https://doi.org/10.1161/01.ATV.0000201938.78044.75",
          "Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, D\u00f6hmen S, Adamis AP (2002) Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. The FASEB Journal 16(3): 438\u2013440. https://doi.org/10.1096/fj.01-0707fje",
          "Janssen-Heininger YM, Poynter ME, Aesif SW, Pantano C, Ather JL, Reynaert NL, Ckless K, Anathy V, van der Velden J, Irvin CG, van der Vliet A (2009) Nuclear factor kappaB, airway epithelium, and asthma: avenues for redox control. Proceedings of the American Thoracic Society 6(3): 249\u2013255. https://doi.org/10.1513/pats.200806-054RM",
          "Jiang N, Chen XL, Yang HW, Ma YR (2015) Effects of nuclear factor \u03baB expression on retinal neovascularization and apoptosis in a diabetic retinopathy rat model. International Journal of Ophthalmology 8(3): 448\u2013452. [Published 2015 Jun 18] https://doi.org/10.3980/j.issn.2222-3959.2015.03.03",
          "Kaltschmidt C, Greiner JFW, Kaltschmidt B (2021) The Transcription Factor NF-\u03baB in Stem Cells and Development. Cells 10(8): 2042. [Published 2021 Aug 10] https://doi.org/10.3390/cells10082042",
          "Kamat AM, Tharakan ST, Sung B, Aggarwal BB (2018) Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF- kappaB and upregulation of TRAIL receptors [published correction appears in Cancer Research 78(17): 5182. https://doi.org/10.1158/0008-5472.CAN-18-1825]. Cancer Research 69(23): 8958\u20138966. https://doi.org/10.1158/0008-5472.CAN-09-2045",
          "Kawai T, Akira S (2007) Signaling to NF-kappaB by Toll-like receptors. Trends in Molecular Medicine 13(11): 460\u2013469. https://doi.org/10.1016/j.molmed.2007.09.002",
          "Ke G, Chen X, Liao R, Xu L, Zhang L, Zhang H, Kuang S, Du Y, Hu J, Lian Z, Dou C, Zhang Q, Zhao X, Zhang F, Zhu S, Ma J, Li Z, Li S, He C, Chen X, Wen Y, Feng Z, Zheng M, Lin T, Li R, Li B, Dong W, Chen Y, Wang W, Ye Z, Deng C, Xiao H, Xiao J, Liang X, Shi W, Liu S (2021) Receptor activator of NF-\u03baB mediates podocyte injury in diabetic nephropathy. Kidney International 100(2): 377\u2013390. https://doi.org/10.1016/j.kint.2021.04.036",
          "Kellogg RA, Tian C, Etzrodt M, Tay S (2017) Cellular Decision Making by Non-Integrative Processing of TLR Inputs. Cell Reports 19(1): 125\u2013135. https://doi.org/10.1016/j.celrep.2017.03.027",
          "Kim SJ, Yoon DH, Kang HJ, Kimd JS, Parke SK, Kimf HJ, Leea J, Ryoob B-Y, Kog YH, Huhh J, Yangi WI, Kimj HK, Mink SK, Leel S-S, Dom I-G, Suhb C, Kim WS (2012) Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: a multicentre, single- arm, phase 2 trial. European Journal of Cancer 48(17): 3223\u20133231. https://doi.org/10.1016/j.ejca.2012.06.003",
          "Kitada M, Zhang Z, Mima A, King GL (2010) Molecular mechanisms of diabetic vascular complications. Journal of Diabetes Investigation 1(3): 77\u201389. https://doi.org/10.1111/j.2040-1124.2010.00018.x",
          "Koerner L, Schmiel M, Yang TP, Peifer M, Buettner R, Pasparakis M (2023) NEMO- and RelA- dependent NF-\u03baB signaling promotes small cell lung cancer. Cell Death & Differentiation 30(4): 938\u2013951. https://doi.org/10.1038/s41418-023-01112-5",
          "Koide N, Kaneda A, Yokochi T, Umezawa K (2015) Inhibition of RANKL- and LPS-induced osteoclast differentiations by novel NF-\u03baB inhibitor DTCM-glutarimide. International Immunopharmacology 25(1): 162\u2013168. https://doi.org/10.1016/j.intimp.2015.01.004",
          "Kong Q, Wang B, Zhong Y, Chen W, Sun J, Liu B, Dong J (2024) Modified Bushen Yiqi Formula mitigates pulmonary inflammation and airway remodeling by inhibiting neutrophils chemotaxis and IL17 signaling pathway in rats with COPD. Journal of Ethnopharmacology 321: 117497. https://doi.org/10.1016/j.jep.2023.117497",
          "Kumar H, Kawai T, Akira S (2011) Pathogen recognition by the innate immune system. International Reviews of Immunology 30(1): 16\u201334. https://doi.org/10.3109/08830185.2010.529976",
          "Kunnumakkara AB, Shabnam B, Girisa S et al. (2020) Inflammation, NF-\u03baB, and Chronic Diseases: How are They Linked? Critical Reviews in Immunology 40(1): 1\u201339. https://doi.org/10.1615/CritRevImmunol.2020033210",
          "Lakhdari O, Tap J, B\u00e9guet-Crespel F, Le Roux K, de Wouters T, Cultrone A, Nepelska M, Lef\u00e8vre F, Dor\u00e9 J, Blotti\u00e8re HM (2011) Identification of NF-\u03baB modulation capabilities within human intestinal commensal bacteria. Journal of Biotechnology and Biomedicine 2011: 282356. https://doi.org/10.1155/2011/282356",
          "Lee KH, Ahn BS, Cha D, Jang WW, Choi E, Park S, Park JJ, Oh J, Jung DD, Park H, Park JJ, Suh Y, Jin D, Lee S, Jang Y-H, Yoon T, Park M-K, Seong Y, Pyo J, Yang S, Kwon Y, Jung H, Lim CC, Hong JJ, Park Y, Choi E, Shin JJ, Kronbichler A (2020) Understanding the immunopathogenesis of autoimmune diseases by animal studies using gene modulation: A comprehensive review. Autoimmunity Reviews 19(3): 102469. https://doi.org/10.1016/j.autrev.2020.102469",
          "Lee N, Heo YJ, Choi SE, Jeon JY, Han SJ, Kim DJ, Kang Y, Lee KW, Kim HJ (2021) Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-\u03baB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways.Journal of Immunology Research 2021: 9944880. [Published 2021 Jun 2] https://doi.org/10.1155/2021/9944880",
          "Liang WJ, Yang HW, Liu HN, Qian W, Chen XL (2020) HMGB1 upregulates NF-kB by inhibiting IKB-\u03b1 and associates with diabetic retinopathy. Life Science 241: 117146. https://doi.org/10.1016/j.lfs.2019.117146",
          "Lin Z, Liao L, Zhao S, Gu W, Wang G, Shen Z, Wang Y, Chen K, Liu W, Cai Y, Wan C, Yan T (2023) Corylin inhibits the progression of Non-small cell lung cancer cells by regulating NF-\u03baB signaling pathway via targeting p65. Phytomedicine 110: 154627. https://doi.org/10.1016/j.phymed.2022.154627",
          "Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduction and Targeted Therapy 2: 17023. https://doi.org/10.1038/sigtrans.2017.23",
          "Lu L, Zhu C, Xu J, Hu Y, Dai J, Wang S, Wei T (2024) Therapeutic Effects of Lifei Decoction in a Murine Model of COPD Induced by LPS and Cigarette Smoke. International Journal of Chronic Obstructive Pulmonary Disease 19: 957\u2013967. [Published 2024 Apr 18] https://doi.org/10.2147/COPD.S449521",
          "Luo KW, Wei Chen, Lung WY, Wei X-Y, Cheng B-H, Cai Z-M, Huang W-R (2017) EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-\u03baB and MMP-9 [published correction appears in J Nutr Biochem. 2024 Jan;123: 109530.]. The Journal of Nutritional Biochemistry 41: 56\u201364. https://doi.org/10.1016/j.jnutbio.2016.12.004",
          "Luo KW, Zhu XH, Zhao T, Zhong J, Gao H-c, Lu X-L, Huang W-R (2020) EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-\u03baB/MDM2/p53 Pathway. Frontiers in Cell and Developmental Biology 8: 606123. [Published 2020 Dec 23] https://doi.org/10.3389/fcell.2020.606123",
          "Ma P, Luo Y, Zhu X, Ma H, Hu J, Tang S (2009) Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat. Biochemical and Biophysical Research Communications 380(2): 402\u2013406. https://doi.org/10.1016/j.bbrc.2009.01.092",
          "MacNee W, Tuder RM (2009) New paradigms in the pathogenesis of chronic obstructive pulmonary disease I. Proceedings of the American Thoracic Society 6(6): 527\u2013531. https://doi.org/10.1513/pats.200905-027DS",
          "Magliano DJ, Boyko EJ (2023) IDF Diabetes Atlas 10th edition scientific committee . IDF Diabetes Atlas. 10th edn. Brussels: International Diabetes Federation; 2021.",
          "Matsumori A (2023) Nuclear factor-\u03baB is a prime candidate for the diagnosis and control of inflammatory cardiovascular disease. European Cardiology Review 18: e40. [Published 2023 Jun 7] https://doi.org/10.15420/ecr.2023.10",
          "Matsumori A (2022) Targeting Inflammation in the Diagnosis, Management, and Prevention of Cardiovascular Diseases. Global Heart 17(1): 80. [Published 2022 Nov 2] https://doi.org/10.5334/gh.1156",
          "Medeiros MC, Frasnelli SC, Bastos Ade S, Orrico SR, Rossa Jr C (2014) Modulation of cell proliferation, survival and gene expression by RAGE and TLR signaling in cells of the innate and adaptive immune response: role of p38 MAPK and NF-KB. Journal of Applied Oral Science 22(3): 185\u2013193. https://doi.org/10.1590/1678-775720130593",
          "Meyerovich K, Ortis F, Cardozo AK (2018) The non-canonical NF-\u03baB pathway and its contribution to \u03b2-cell failure in diabetes. Journal of Molecular Endocrinology 61(2): F1\u2013F6. https://doi.org/10.1530/JME-16-0183",
          "Michels da Silva D, Langer H, Graf T (2019) Inflammatory and Molecular Pathways in Heart Failure-Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis. International Journal of Molecular Sciences 20(9): 2322. [Published 2019 May 10] https://doi.org/10.3390/ijms20092322",
          "Mirzaei S, Saghari S, Bassiri F, Raesi R, Zarrabi A, Hushmandi K, Sethi G, Tergaonkar V (2022) NF-\u03baB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition. Journal of Cellular Physiology 237(7): 2770\u20132795. https://doi.org/10.1002/jcp.30759",
          "Mukherjee N, Houston TJ, Cardenas E, Ghosh R (2015) To be an ally or an adversary in bladder cancer: the NF-\u03baB story has not unfolded. Carcinogenesis 36(3): 299\u2013306. https://doi.org/10.1093/carcin/bgu321",
          "Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, Yamashiro K, Inoue M, Tsubota K, Umezawa K, Ishida S (2007) Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Investigative Ophthalmology & Visual Science 48(9): 4342\u20134350. https://doi.org/10.1167/iovs.06-1473",
          "Nakanishi C, Toi M (2005) Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nature Reviews Cancer 5(4): 297\u2013309. https://doi.org/10.1038/nrc1588",
          "Nan J, Du Y, Chen X, Bai Q, Wang Y, Zhang X, Zhu N, Zhang J, Hou J, Wang Q, Yang J (2014) TPCA-1 is a direct dual inhibitor of STAT3 and NF-\u03baB and regresses mutant EGFR-associated human non-small cell lung cancers. Molecular Cancer Therapeutics 13(3): 617\u2013629. https://doi.org/10.1158/1535-7163.MCT-13-0464",
          "Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu X-F, Ireland MA, Lenderink T, Latchem D, Hoogslag P, Jerzewski A, Nierop P, Whelan A, Hendriks R, Swart H, Schaap J, Kuijper AFM, van Hessen MWJ, Saklani P, Tan I, Thompson AG, Morton A, Judkins C, Bax WA, Dirksen M, Alings M, Hankey GJ, Budgeon CA, Tijssen JGP, Cornel JH, Thompson PL (2020) Colchicine in Patients with Chronic Coronary Disease. The New England Journal of Medicine 383(19): 1838\u20131847. https://doi.org/10.1056/NEJMoa2021372",
          "Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhausa M, PPoole-Wilson A, Coats AJS, Anker SD (1999) Endotoxin and immune activation in chronic heart failure: a prospective cohort study. The Lancet 353(9167): 1838\u20131842. https://doi.org/10.1016/S0140-6736(98)09286-1",
          "Oeckinghaus A, Ghosh S (2009) The NF-kappaB family of transcription factors and its regulation. Cold Spring Harbor Perspectives in Biology 1(4): a000034. https://doi.org/10.1101/cshperspect.a000034",
          "Oeckinghaus A, Hayden MS, Ghosh S (2011) Crosstalk in NF-\u03baB signaling pathways. Nature Immunology 12(8): 695\u2013708. [Published 2011 Jul 19] https://doi.org/10.1038/ni.2065",
          "Patel S, Santani D (2009) Role of NF-kappa B in the pathogenesis of diabetes and its associated complications. Pharmacological Reports 61(4): 595\u2013603. https://doi.org/10.1016/s1734-1140(09)70111-2",
          "Pavitra E, Kancharla J, Gupta VK, Prasad K, Sung JY, Kim J, Tej MB, Choi R, Lee J-H, Han Y-K, Raju GSR, Bhaskar LVKS, Huh YS. (2023) The role of NF-\u03baB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy. Biomedicine & Pharmacotherapy 163: 114822. https://doi.org/10.1016/j.biopha.2023.114822",
          "Pereira SS, Alvarez-Leite JI (2014) Low-Grade Inflammation, Obesity, and Diabetes. Current Obesity Reports 3(4): 422\u2013431. https://doi.org/10.1007/s13679-014-0124-9",
          "Pulitzer M (2017) Cutaneous T-cell Lymphoma. Clinics in Laboratory Medicine 37(3): 527\u2013546. https://doi.org/10.1016/j.cll.2017.06.006",
          "Qin J, Wang Y, Bai Y, Yang K, Mao Q, Lin Y, Kong D, Zheng X, Xie L (2012) Epigallocatechin-3-gallate inhibits bladder cancer cell invasion via suppression of NF-\u03baB mediated matrix metalloproteinase-9 expression. Molecular Medicine Reports 6(5): 1040\u20131044. https://doi.org/10.3892/mmr.2012.1054",
          "Qin J, Xie LP, Zheng XY, Wang Y-B, Bai Y, Shen H-F, Li L-C, Dahiya R (2007) A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochemical and Biophysical Research Communications 354(4): 852\u2013857. https://doi.org/10.1016/j.bbrc.2007.01.003",
          "Que D, Kuang F, Kang R, Tang D, Liu J (2023) ACSS2-mediated NF-\u03baB activation promotes alkaliptosis in human pancreatic cancer cells. Scientific Reports 13(1): 1483. [Published 2023 Jan 27] https://doi.org/10.1038/s41598-023-28261-4",
          "Rasmi RR, Sakthivel KM, Guruvayoorappan C (2020) NF-\u03baB inhibitors in treatment and prevention of lung cancer. Biomedicine & Pharmacotherapy 130: 110569. https://doi.org/10.1016/j.biopha.2020.110569",
          "Recovery Collaborative Group, Horby P,Lim WS, et al. (2021) Dexamethasone in Hospitalized Patients with Covid-19. The New England Journal of Medicine 384(8): 693\u2013704. https://doi.org/10.1056/NEJMoa2021436",
          "Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, JCornel H, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ (2017) Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. The New England Journal of Medicine 377(12): 1119\u20131131. https://doi.org/10.1056/NEJMoa1707914",
          "Rieger-Fackeldey E, Hentschel R (2008) Bronchopulmonary dysplasia and early prophylactic inhaled nitric oxide in preterm infants: current concepts and future research strategies in animal models. Journal of Perinatal Medicine. 36(5): 442\u2013447. https://doi.org/10.1515/JPM.2008.065",
          "Rishi L, Dhiman R, Raje M, Majumdar S (2007) Nitric oxide induces apoptosis in cutaneous T cell lymphoma (HuT-78) by downregulating constitutive NF-kappaB. Biochimica et Biophysica Acta 1770(8): 1230\u20131239. https://doi.org/10.1016/j.bbagen.2007.04.011",
          "Robles JP, Zamora M, Adan-Castro E, Siqueiros-Marquez L, Martinez de la Escalera G, Clapp C (2022) The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin \u03b15\u03b21 and NF-\u03baB signaling. Journal of Biological Chemistry 298(3): 101695. https://doi.org/10.1016/j.jbc.2022.101695",
          "Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46(5): 705\u2013716. https://doi.org/10.1016/0092-8674(86)90346-6",
          "Sheu KM, Hoffmann A (2022) Functional Hallmarks of Healthy Macrophage Responses: Their Regulatory Basis and Disease Relevance. Annual Review of Immunology 40: 295\u2013321. https://doi.org/10.1146/annurev-immunol-101320-031555",
          "Sors A, Jean-Louis F, B\u00e9gu\u00e9 E, Parmentier L, Dubertret L, Dreano M, Courtois G, Herv\u00e9 Bachelez, Michel L (2008) Inhibition of IkappaB kinase subunit 2 in cutaneous T- cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents. Clinical Cancer Research 14(3): 901\u2013911. https://doi.org/10.1158/1078-0432.CCR-07-1419",
          "Sreenivasan Y, Sarkar A, Manna SK (2003) Mechanism of cytosine arabinoside-mediated apoptosis: role of Rel A (p65) dephosphorylation. Oncogene 22(28): 4356\u20134369. https://doi.org/10.1038/sj.onc.1206486",
          "Tang J, Kern TS (2011) Inflammation in diabetic retinopathy. Progress in Retinal and Eye Research 30(5): 343\u2013358. https://doi.org/10.1016/j.preteyeres.2011.05.002",
          "Tsai DH, Riediker M, Berchet A, Paccaud F, Waeber G, Vollenweider P, Bochud M. (2019) Effects of short- and long-term exposures to particulate matter on inflammatory marker levels in the general population. Environmental Science and Pollution Research 26(19): 19697\u201319704. https://doi.org/10.1007/s11356-019-05194-y",
          "Tun-Kyi A, Qin JZ, Oberholzer PA, Navarini AA, Hassel JC, Dummer R, D\u00f6bbeling U. (2008) Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model. Annals of Oncology 19(8): 1488\u20131494. https://doi.org/10.1093/annonc/mdn056",
          "Valencia JC, Egbukichi N, Erwin-Cohen RA (2019) Autoimmunity and Cancer, the Paradox Comorbidities Challenging Therapy in the Context of Preexisting Autoimmunity. Journal of Interferon & Cytokine Research 39(1): 72\u201384. https://doi.org/10.1089/jir.2018.0060",
          "Walter CEJ, Durairajan S, Periyandavan K et al. (2020) Bladder neoplasms and NF-\u03baB: an unfathomed association. Expert Review of Molecular Diagnostics 20(5): 497\u2013508. https://doi.org/10.1080/14737159.2020.1743688",
          "Wang J, Xu X, Elliott MH, Zhu M, Le YZ (2010) M\u00fcller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes 59(9): 2297\u20132305. https://doi.org/10.2337/db09-1420",
          "Wang MD, Li HT, Peng LX, Mei Y, Zheng L-S, Li C-Z, Meng D-F, Lang Y-H, Xu L, Peng X-S, Liu Z-J, Xie D-H, Guo L-L, Ma M-G, Ding L-Y, Huang B-J, Cao Y, Qian C-N (2024) TSPAN1 inhibits metastasis of nasopharyngeal carcinoma via suppressing NF-kB signaling. Cancer Gene Therapy 31(3): 454\u2013463. https://doi.org/10.1038/s41417-023-00716-w",
          "Wang SY, Andrews CA, Herman WH, Gardner TW, Stein JD (2017) Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States. Ophthalmology 124(4): 424\u2013430. https://doi.org/10.1016/j.ophtha.2016.10.031",
          "Wang X, Shen Y, MengLv L, Zhang XM, Yang J, Wang F, Yang J. (2020) Thalidomide suppresses breast cancer tumor growth by inhibiting tumor-associated macrophage accumulation in breast tumor-bearing mice. European Journal of Pharmaceutical Sciences 151: 105302. https://doi.org/10.1016/j.ejps.2020.105302",
          "Woo SL, Xu H, Li H, Zhao Y, Hu X, Zhao J, Guo X, Guo T, Botchlett R, Qi T, Pei Y, Zheng J, Xu Y, An X, Chen L, Chen L, Li Q, Xiao X, Huo Y, Wu C. (2014) Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity. PLoS ONE 9(3): e91111. [Published 2014 Mar 17] https://doi.org/10.1371/journal.pone.0091111",
          "Yang F, Zeng F, Luo X, Lei Y, Li J, Lu S, Huang X, Lan Y, Liu R (2021) GLP-1 receptor: A new target for sepsis. Frontiers in Pharmacology 12: 706908. [Published 2021 Jul 14] https://doi.org/10.3389/fphar.2021.706908",
          "Ye X, Ding J, Zhou X, Chen G, Liu SF (2008) Divergent roles of endothelial NF-kappaB in multiple organ injury and bacterial clearance in mouse models of sepsis [published correction appears in J Exp Med. 2008 Jun 9;205(6):1509]. Ournal of Experimental Medicine 205(6): 1303\u20131315. https://doi.org/10.1084/jem.20071393",
          "Ye Z, Wang Y, Colunga-Lozano LE, Prasad M, Tangamornsuksan W, Rochwerg B, Yao L, Motaghi S, Couban RJ, Ghadimi M, Bala MM, Gomaa H, Fang FYX, Guyatt GH (2020) Efficacy and safety of corticosteroids in COVID- 19 based on evidence for COVID-19, other coronavirus infections, influenza, community- acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta- analysis. CMAJ 192(27): E756\u2013E767. https://doi.org/10.1503/CMAJ200645",
          "Yi YW, You KS, Han S, Ha IJ, Park J-S, Lee S-G, Seong Y-S (2022) Inhibition of I\u03baB kinase is a potential therapeutic strategy to circumvent resistance to epidermal growth factor receptor inhibition in triple-negative breast cancer cells. Cancers (Basel) 14(21): 5215. [Published 2022 Oct 24] https://doi.org/10.3390/cancers14215215",
          "Zamanian MY, Alsaab HO, Golmohammadi M, Yumashev A, Jabba AM, Abid MK, Joshi A, Alawadi AH, Jafer NS, Kianifar F, S Obakir B (2024) NF-\u03baB pathway as a molecular target for curcumin in diabetes mellitus treatment: Focusing on oxidative stress and inflammation. Cell Biochemistry and Function 42(4): e4030. https://doi.org/10.1002/cbf.4030",
          "Zhang C, Li B, Zhang X, Hazarika P, Aggarwal BB, Duvic M (2010) Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling. Journal of Investigative Dermatology 130(8): 2110\u20132119. https://doi.org/10.1038/jid.2010.86",
          "Zhang Q, Lenardo MJ, Baltimore D (2017) 30 Years of NF-\u03baB: A Blossoming of Relevance to Human Pathobiology. Cell 168(1\u20132): 37\u201357. https://doi.org/10.1016/j.cell.2016.12.012",
          "Zhang X, Wu X, Hu Q, Wu J, Wang G, Hong Z, Ren J (2019) Mitochondrial DNA in liver inflammation and oxidative stress. Life Science 236: 116464. https://doi.org/10.1016/j.lfs.2019.05.020",
          "Zinzani PL, Musuraca G, Tani M, Stefoni V, Marchi E, Fina M, Pellegrini C, Alinari L, Derenzini E, de Vivo A, Sabattini E, Pileri S, Baccarani M (2007) Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma. Journal of Clinical Oncology 25(27): 4293\u20134297. https://doi.org/10.1200/JCO.2007.11.4207"
        ],
        "resource_type": {
          "title": "Journal article",
          "type": "publication",
          "subtype": "article"
        },
        "journal": {
          "issue": "",
          "pages": "1-13",
          "title": "Pharmacia",
          "volume": "72"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "14909278"
              }
            }
          ]
        }
      },
      "title": "The role of the transcription factor NF-kB in the pathogenesis of inflammation and carcinogenesis. Modulation capabilities",
      "links": {
        "self": "https://zenodo.org/api/records/14909279",
        "self_html": "https://zenodo.org/records/14909279",
        "doi": "https://doi.org/10.3897/pharmacia.72.e146759",
        "self_doi": "https://doi.org/10.3897/pharmacia.72.e146759",
        "self_doi_html": "https://zenodo.org/doi/10.3897/pharmacia.72.e146759",
        "parent": "https://zenodo.org/api/records/14909278",
        "parent_html": "https://zenodo.org/records/14909278",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:14909279/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:14909279/sequence/default",
        "files": "https://zenodo.org/api/records/14909279/files",
        "media_files": "https://zenodo.org/api/records/14909279/media-files",
        "thumbnails": {
          "10": "https://zenodo.org/api/iiif/record:14909279:PHAR_article_146759.pdf/full/^10,/0/default.jpg",
          "50": "https://zenodo.org/api/iiif/record:14909279:PHAR_article_146759.pdf/full/^50,/0/default.jpg",
          "100": "https://zenodo.org/api/iiif/record:14909279:PHAR_article_146759.pdf/full/^100,/0/default.jpg",
          "250": "https://zenodo.org/api/iiif/record:14909279:PHAR_article_146759.pdf/full/^250,/0/default.jpg",
          "750": "https://zenodo.org/api/iiif/record:14909279:PHAR_article_146759.pdf/full/^750,/0/default.jpg",
          "1200": "https://zenodo.org/api/iiif/record:14909279:PHAR_article_146759.pdf/full/^1200,/0/default.jpg"
        },
        "archive": "https://zenodo.org/api/records/14909279/files-archive",
        "archive_media": "https://zenodo.org/api/records/14909279/media-files-archive",
        "latest": "https://zenodo.org/api/records/14909279/versions/latest",
        "latest_html": "https://zenodo.org/records/14909279/latest",
        "versions": "https://zenodo.org/api/records/14909279/versions",
        "draft": "https://zenodo.org/api/records/14909279/draft",
        "reserve_doi": "https://zenodo.org/api/records/14909279/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/14909279/access/links",
        "access_grants": "https://zenodo.org/api/records/14909279/access/grants",
        "access_users": "https://zenodo.org/api/records/14909279/access/users",
        "access_request": "https://zenodo.org/api/records/14909279/access/request",
        "access": "https://zenodo.org/api/records/14909279/access",
        "communities": "https://zenodo.org/api/records/14909279/communities",
        "communities-suggestions": "https://zenodo.org/api/records/14909279/communities-suggestions",
        "requests": "https://zenodo.org/api/records/14909279/requests"
      },
      "updated": "2025-02-22T08:31:26.127244+00:00",
      "recid": "14909279",
      "revision": 4,
      "files": [
        {
          "id": "e0aa385d-91fd-4eed-81e3-cf51c0ee19cd",
          "key": "PHAR_article_146759.pdf",
          "size": 358208,
          "checksum": "md5:6f9c58544cf03093c463bf2900eabdef",
          "links": {
            "self": "https://zenodo.org/api/records/14909279/files/PHAR_article_146759.pdf/content"
          }
        },
        {
          "id": "0fe5da20-4971-4d61-9083-16c2dbad19b7",
          "key": "PHAR_article_146759.xml",
          "size": 211309,
          "checksum": "md5:757969ce0bdffca6024d1cbcb3f63c05",
          "links": {
            "self": "https://zenodo.org/api/records/14909279/files/PHAR_article_146759.xml/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "22270"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 9,
        "unique_downloads": 9,
        "views": 7,
        "unique_views": 7,
        "version_downloads": 9,
        "version_unique_downloads": 9,
        "version_unique_views": 7,
        "version_views": 7
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-02-08T12:32:01.889337+00:00",
      "modified": "2025-02-08T12:32:02.117631+00:00",
      "id": 14836860,
      "conceptrecid": "14836859",
      "doi": "10.5281/zenodo.14836860",
      "conceptdoi": "10.5281/zenodo.14836859",
      "doi_url": "https://doi.org/10.5281/zenodo.14836860",
      "metadata": {
        "title": "The role of palmitoylation of the insulin receptor in insulin resistance: A hypothesis",
        "doi": "10.5281/zenodo.14836860",
        "publication_date": "2024-08-30",
        "description": "<p>Palmitoylation is attachment of a palmitoyl group to the cysteine residues of a protein. The intermediary in this process is Palmitoyl CoA, which is formed during the activation of fatty acids in the beta oxidationn of the palmitic acid, consequent to the shift of the energy metabolism to beta oxidation from glycolysis, in DM2.The insulin receptor has cysteine rich domains in the cytosolic portion of the beta sub unit connected by disulfide bonds. It is hypothesized that the palmitoylation forms a thio-ester bond with cystein residues of the beta sub units of the insulin receptor. Depalmitoylation results in substitution of thiol (-SH) in place of the disulfide (S-S) bonds (S-S), due to the hydrolysis by the thio-esterase enzyme. The disulfide bonds are responsible for formation of the functional tettameric form of the insulin receptor. Consequent to the substitution of the SH group in place of S-S group, during depalmitoylation, the functional specificity of the insulin receptor is lost. This leads to the failure of conformational changes and auto- phoshorylation of the beta sub units when insulin binds to the extra cellular insulin binding receptor domain. Also failure of the cascade of phosphorylation of other signalling proteins occurs. Consequently, the failure of the intra- cellular transduction of the signals results in failure of the translocation of the GLUT 4 transporter to the cell membrane. This results in the hyperglycaemia in spite of hyper insulinemia and mo glucose enters into the cell- a state called insulin resistance in DM 2.</p>",
        "access_right": "open",
        "creators": [
          {
            "name": "ASV PRASAD",
            "affiliation": "Former Faculty member, Department of internal Medicine, G.I.T.A.M Dental College, Rishikonda, Visakhapatnam, Andhra Pradesh India."
          }
        ],
        "keywords": [
          "Palmitoylation",
          "Insulin receptor",
          "Insulin resistance",
          "Beta oxidation of fats Acetyl CoA",
          "GLUT 4"
        ],
        "language": "eng",
        "resource_type": {
          "title": "Journal article",
          "type": "publication",
          "subtype": "article"
        },
        "journal": {
          "issue": "2",
          "pages": "328\u2013331",
          "title": "World Journal of Advanced Research and Reviews",
          "volume": "23"
        },
        "alternate_identifiers": [
          {
            "identifier": "10.30574/wjarr.2024.23.2.2324"
          }
        ],
        "license": {
          "id": "cc-by-4.0"
        },
        "communities": [
          {
            "id": "wjarr"
          }
        ],
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "14836859"
              }
            }
          ]
        }
      },
      "title": "The role of palmitoylation of the insulin receptor in insulin resistance: A hypothesis",
      "links": {
        "self": "https://zenodo.org/api/records/14836860",
        "self_html": "https://zenodo.org/records/14836860",
        "doi": "https://doi.org/10.5281/zenodo.14836860",
        "self_doi": "https://doi.org/10.5281/zenodo.14836860",
        "self_doi_html": "https://zenodo.org/doi/10.5281/zenodo.14836860",
        "parent": "https://zenodo.org/api/records/14836859",
        "parent_html": "https://zenodo.org/records/14836859",
        "parent_doi": "https://doi.org/10.5281/zenodo.14836859",
        "parent_doi_html": "https://zenodo.org/doi/10.5281/zenodo.14836859",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:14836860/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:14836860/sequence/default",
        "files": "https://zenodo.org/api/records/14836860/files",
        "media_files": "https://zenodo.org/api/records/14836860/media-files",
        "thumbnails": {
          "10": "https://zenodo.org/api/iiif/record:14836860:WJARR-2024-2324.pdf/full/^10,/0/default.jpg",
          "50": "https://zenodo.org/api/iiif/record:14836860:WJARR-2024-2324.pdf/full/^50,/0/default.jpg",
          "100": "https://zenodo.org/api/iiif/record:14836860:WJARR-2024-2324.pdf/full/^100,/0/default.jpg",
          "250": "https://zenodo.org/api/iiif/record:14836860:WJARR-2024-2324.pdf/full/^250,/0/default.jpg",
          "750": "https://zenodo.org/api/iiif/record:14836860:WJARR-2024-2324.pdf/full/^750,/0/default.jpg",
          "1200": "https://zenodo.org/api/iiif/record:14836860:WJARR-2024-2324.pdf/full/^1200,/0/default.jpg"
        },
        "archive": "https://zenodo.org/api/records/14836860/files-archive",
        "archive_media": "https://zenodo.org/api/records/14836860/media-files-archive",
        "latest": "https://zenodo.org/api/records/14836860/versions/latest",
        "latest_html": "https://zenodo.org/records/14836860/latest",
        "versions": "https://zenodo.org/api/records/14836860/versions",
        "draft": "https://zenodo.org/api/records/14836860/draft",
        "reserve_doi": "https://zenodo.org/api/records/14836860/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/14836860/access/links",
        "access_grants": "https://zenodo.org/api/records/14836860/access/grants",
        "access_users": "https://zenodo.org/api/records/14836860/access/users",
        "access_request": "https://zenodo.org/api/records/14836860/access/request",
        "access": "https://zenodo.org/api/records/14836860/access",
        "communities": "https://zenodo.org/api/records/14836860/communities",
        "communities-suggestions": "https://zenodo.org/api/records/14836860/communities-suggestions",
        "requests": "https://zenodo.org/api/records/14836860/requests"
      },
      "updated": "2025-02-08T12:32:02.117631+00:00",
      "recid": "14836860",
      "revision": 4,
      "files": [
        {
          "id": "c0383531-dceb-48b8-b048-74213bcf2d6d",
          "key": "WJARR-2024-2324.pdf",
          "size": 833226,
          "checksum": "md5:bc3e693aba52aad4a5ddbcfa0f932dec",
          "links": {
            "self": "https://zenodo.org/api/records/14836860/files/WJARR-2024-2324.pdf/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "155121"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 21,
        "unique_downloads": 19,
        "views": 19,
        "unique_views": 17,
        "version_downloads": 21,
        "version_unique_downloads": 19,
        "version_unique_views": 17,
        "version_views": 19
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-02-07T10:04:07.039601+00:00",
      "modified": "2025-02-07T10:04:07.214281+00:00",
      "id": 14831806,
      "conceptrecid": "14831805",
      "doi": "10.5281/zenodo.14831806",
      "conceptdoi": "10.5281/zenodo.14831805",
      "doi_url": "https://doi.org/10.5281/zenodo.14831806",
      "metadata": {
        "title": "Data set related to the article: \"Klebsiella pneumoniae-OMVs activate death-signaling pathways in Human Bronchial Epithelial Host Cells (BEAS-2B)\"",
        "doi": "10.5281/zenodo.14831806",
        "publication_date": "2025-02-07",
        "description": "<p>The programmed cell death pathways of apoptosis are important in mammalian cellular protection<br>from infections. The activation of these pathways depends on the presence of membrane<br>receptors that bind bacterial components to activate the transduction mechanism. In addition to<br>bacteria, these mechanisms can be activated by outer membrane vesicles (OMVs). OMVs are<br>spherical vesicles of 20&ndash;250 nm diameter, constitutively released by Gram-negative bacteria.<br>They contain several bacterial determinants including proteins, DNA/RNA and proteins, that<br>activate different cellular processes in host cells. This study focused on Klebsiella pneumoniae-<br>OMVs in activating death mechanisms in human bronchial epithelial cells (BEAS-2B). Characterization<br>of purified OMVs was achieved by scanning electron microscopy, nanoparticle tracking<br>analysis and protein profiling. Cell viability was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-<br>diphenyltetrazolium bromide assay while apoptotic induction was measured by flow cytometry<br>and confirmed by western blotting. The OMVs produced showed a spherical morphology, with a<br>diameter of 137.2 &plusmn; 41 nm and a vesicular density of 7.8 &times; 109 particles/mL Exposure of cell<br>monolayers to 50 &mu;g of K. pneumoniae-OMV for 14 h resulted in approximately 25 % cytotoxicity<br>and 41.15&ndash;41.14 % of cells undergoing early and late apoptosis. Fluorescence microscopy<br>revealed reduced cellular density, the presence of apoptotic bodies, chromatin condensation, and<br>nuclear membrane blebbing in residual cells. Activation of caspases \udbc0\udc00 3 and \udbc0\udc00 9 and dysregulation<br>of BAX, BIM and Bcl-xL indicated the activation of mitochondria-dependent apoptosis. Furthermore,<br>a decrease in the antioxidant enzymes superoxide dismutase, catalase and glutathione<br>peroxidase involved endoplasmic reticulum stress with the potential formation of reactive oxygen species.</p>\n<p>These findings provide evidence for the role of OMVs in apoptosis and involvement in the<br>pathogenesis of K. pneumoniae infections.</p>",
        "access_right": "restricted",
        "creators": [
          {
            "name": "Maciag, Anna",
            "affiliation": "Cardiovascular Research Unit, IRCCS MultiMedica, 20138, Milan, Italy"
          }
        ],
        "contributors": [
          {
            "name": "Dell'Annunziata, Federica",
            "affiliation": "Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\", University of Salerno, 84081, Baronissi, Salerno, Italy",
            "type": "Researcher"
          },
          {
            "name": "Ciaglia, Elena",
            "affiliation": "Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\", University of Salerno, 84081, Baronissi, Salerno, Italy",
            "type": "Researcher"
          },
          {
            "name": "Folliero, Veronica",
            "affiliation": "Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\", University of Salerno, 84081, Baronissi, Salerno, Italy",
            "type": "Researcher"
          },
          {
            "name": "Lopardo, Valentina",
            "affiliation": "Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\", University of Salerno, 84081, Baronissi, Salerno, Italy",
            "type": "Researcher"
          },
          {
            "name": "Maciag, Anna",
            "affiliation": "Cardiovascular Research Unit, IRCCS MultiMedica, 20138, Milan, Italy",
            "type": "Researcher",
            "orcid": "0000-0001-6562-5640"
          },
          {
            "name": "Galdiero, Massimiliano",
            "affiliation": "Department of Experimental Medicine, University of Campania Luigi Vanvitelli, 80138, Naples, Italy",
            "type": "Researcher"
          },
          {
            "name": "Puca, Annibale Alessandro",
            "affiliation": "Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\", University of Salerno, 84081, Baronissi, Salerno, Italy",
            "type": "ContactPerson"
          },
          {
            "name": "Franci, Gianluigi",
            "affiliation": "Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\", University of Salerno, 84081, Baronissi, Salerno, Italy",
            "type": "ContactPerson"
          }
        ],
        "keywords": [
          "Klebsiella pneumoniae Outer membrane vesicles Virulence Apoptosis Host-pathogen interaction Endoplasmic reticulum stress"
        ],
        "dates": [
          {
            "type": "created"
          }
        ],
        "references": [
          "https://doi.org/10.1016/j.heliyon.2024.e29017"
        ],
        "resource_type": {
          "title": "Dataset",
          "type": "dataset"
        },
        "journal": {
          "title": "Heliyon"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "communities": [
          {
            "id": "multimedica"
          }
        ],
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "14831805"
              }
            }
          ]
        }
      },
      "title": "Data set related to the article: \"Klebsiella pneumoniae-OMVs activate death-signaling pathways in Human Bronchial Epithelial Host Cells (BEAS-2B)\"",
      "links": {
        "self": "https://zenodo.org/api/records/14831806",
        "self_html": "https://zenodo.org/records/14831806",
        "doi": "https://doi.org/10.5281/zenodo.14831806",
        "self_doi": "https://doi.org/10.5281/zenodo.14831806",
        "self_doi_html": "https://zenodo.org/doi/10.5281/zenodo.14831806",
        "parent": "https://zenodo.org/api/records/14831805",
        "parent_html": "https://zenodo.org/records/14831805",
        "parent_doi": "https://doi.org/10.5281/zenodo.14831805",
        "parent_doi_html": "https://zenodo.org/doi/10.5281/zenodo.14831805",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:14831806/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:14831806/sequence/default",
        "files": "https://zenodo.org/api/records/14831806/files",
        "media_files": "https://zenodo.org/api/records/14831806/media-files",
        "archive": "https://zenodo.org/api/records/14831806/files-archive",
        "archive_media": "https://zenodo.org/api/records/14831806/media-files-archive",
        "latest": "https://zenodo.org/api/records/14831806/versions/latest",
        "latest_html": "https://zenodo.org/records/14831806/latest",
        "versions": "https://zenodo.org/api/records/14831806/versions",
        "draft": "https://zenodo.org/api/records/14831806/draft",
        "reserve_doi": "https://zenodo.org/api/records/14831806/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/14831806/access/links",
        "access_grants": "https://zenodo.org/api/records/14831806/access/grants",
        "access_users": "https://zenodo.org/api/records/14831806/access/users",
        "access_request": "https://zenodo.org/api/records/14831806/access/request",
        "access": "https://zenodo.org/api/records/14831806/access",
        "communities": "https://zenodo.org/api/records/14831806/communities",
        "communities-suggestions": "https://zenodo.org/api/records/14831806/communities-suggestions",
        "requests": "https://zenodo.org/api/records/14831806/requests"
      },
      "updated": "2025-02-07T10:04:07.214281+00:00",
      "recid": "14831806",
      "revision": 4,
      "files": [],
      "swh": {},
      "owners": [
        {
          "id": "203357"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 0,
        "unique_downloads": 0,
        "views": 2,
        "unique_views": 2,
        "version_downloads": 0,
        "version_unique_downloads": 0,
        "version_unique_views": 2,
        "version_views": 2
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-02-07T00:31:39.706182+00:00",
      "modified": "2025-02-07T00:37:23.896827+00:00",
      "id": 14828914,
      "conceptrecid": "14828913",
      "doi": "10.1093/zoolinnean/zlz016",
      "doi_url": "https://doi.org/10.1093/zoolinnean/zlz016",
      "metadata": {
        "title": "Evolution of a sensory cluster on the legs of Opiliones (Arachnida) informs multi-level phylogenetic relationships",
        "doi": "10.1093/zoolinnean/zlz016",
        "publication_date": "2019-09-30",
        "description": "Gainett, Guilherme, Sharma, Prashant P, Fernandes, Nath\u00e1lia, Pinto-Da-Rocha, Ricardo, Giribet, Gonzalo, Willemart, Rodrigo Hirata (2019): Evolution of a sensory cluster on the legs of Opiliones (Arachnida) informs multi-level phylogenetic relationships. Zoological Journal of the Linnean Society 187 (1): 143-165, DOI: 10.1093/zoolinnean/zlz016, URL: https://academic.oup.com/zoolinnean/article/187/1/143/5437571",
        "access_right": "restricted",
        "creators": [
          {
            "name": "Gainett, Guilherme",
            "affiliation": null
          },
          {
            "name": "Sharma, Prashant P",
            "affiliation": null
          },
          {
            "name": "Fernandes, Nath\u00e1lia",
            "affiliation": null
          },
          {
            "name": "Pinto-Da-Rocha, Ricardo",
            "affiliation": null
          },
          {
            "name": "Giribet, Gonzalo",
            "affiliation": null
          },
          {
            "name": "Willemart, Rodrigo Hirata",
            "affiliation": null
          }
        ],
        "keywords": [
          "Biodiversity",
          "Taxonomy",
          "Animalia",
          "Arthropoda",
          "Arachnida",
          "Opiliones",
          "Adaeidae;agoristenidae;askawachidae;assamiidae;beloniscidae;biantidae;briggsidae;buemarinoidae;cladonychiidae;cosmetidae;cranaidae;cryptogeobiidae;cryptomastridae;epedanidae;erebomastridae;escadabiidae;fissiphalliidae;gerdesiidae;gonyleptidae;guasiniidae;hinzuanidae;icaleptidae;kimulidae;lomanellidae;manaosbiidae;metasarcidae;nomoclastidae;oncopodidae;otilioleptidae;paralolidae;paranonychidae;pentanychidae;petrobunidae;phalangodidae;podoctidae;prostygnidae;pyramidopidae;samoidae;sandokanidae;stygnidae;stygnommatidae;stygnopsidae;suthepiidae;synthetonychiidae;tithaeidae;travuniidae;triaenobunidae;triaenonychidae;trionyxellidae;zalmoxidae",
          "Acropsopilionidae;dicranolasmatidae;eotrogulidae;halithersidae;ischyropsalididae;nemastomatidae;nemastomoididae;nipponopsalididae;sabaconidae;taracidae;trogulidae",
          "Caddidae;globipedidae;kustarachnidae;neopilionidae;opilionidae;phalangiidae;protolophidae;sclerosomatidae",
          "Neogoveidae;ogoveidae;pettalidae;sironidae;stylocellidae;troglosironidae"
        ],
        "related_identifiers": [
          {
            "identifier": "http://treatment.plazi.org/id/03A2D5375E55FFFDD1B1F924FBC7BDB3",
            "relation": "hasPart",
            "resource_type": "publication-taxonomictreatment",
            "scheme": "url"
          },
          {
            "identifier": "http://treatment.plazi.org/id/03A2D5375E53FFF9D229F9E4FD3FB81F",
            "relation": "hasPart",
            "resource_type": "publication-taxonomictreatment",
            "scheme": "url"
          },
          {
            "identifier": "http://treatment.plazi.org/id/03A2D5375E51FFF9D1B1FB96FB7BB8DC",
            "relation": "hasPart",
            "resource_type": "publication-taxonomictreatment",
            "scheme": "url"
          },
          {
            "identifier": "http://treatment.plazi.org/id/03A2D5375E51FFF5D229FB52FDB6BB37",
            "relation": "hasPart",
            "resource_type": "publication-taxonomictreatment",
            "scheme": "url"
          },
          {
            "identifier": "10.5281/zenodo.14828916",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.5281/zenodo.14828918",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.5281/zenodo.14828920",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.5281/zenodo.14828924",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.5281/zenodo.14828926",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.5281/zenodo.14828928",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.5281/zenodo.14828930",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.5281/zenodo.14828932",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.5281/zenodo.14828934",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.5281/zenodo.14828936",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.5281/zenodo.14828938",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.5281/zenodo.14828940",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.5281/zenodo.14828942",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.5281/zenodo.14828944",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          },
          {
            "identifier": "10.5281/zenodo.14828946",
            "relation": "hasPart",
            "resource_type": "image-figure",
            "scheme": "doi"
          }
        ],
        "references": [
          "Anton S, Tichy H. 1994. Hygro- and thermoreceptors in tippore sensilla of the tarsal organ of the spider Cupiennius salei: innervation and central projection. Cell and Tissue Research 278: 399-407.",
          "Benedetti A. 2012. Revisao e analise cladistica da subfamilia Metasarcinae Kury, 1994 (Opiliones; Laniatores; Gonyleptidae). Unpublished MSc Thesis, Instituto de Biociencias, Universidade de Sao Paulo.",
          "Blumenthal H. 1935. Untersuchungen uber das 'Tarsalorgan' der Spinnen. Zeitschrift fur Morphologie und Okologie der Tiere 29: 667-719.",
          "Botero-Trujillo R, Florez ED. 2011. A revisionary approach of Colombian Ananteris (Scorpiones, Buthidae): two new species, a new synonymy, and notes on the value of trichobothria and hemispermatophore for the taxonomy of the group. Zootaxa 2904: 1-44.",
          "Bragagnolo C, Hara MR, Pinto-da-Rocha R. 2015. A new family of Gonyleptoidea from South America (Opiliones, Laniatores). Zoological Journal of the Linnean Society 173: 296-319.",
          "Brazeau MD. 2011. Problematic character coding methods in morphology and their effects. Biological Journal of the Linnean Society 104: 489-498.",
          "Brozek J, Zettel H. 2014. A comparison of the external morphology and functions of labial tip sensilla. European Journal of Entomology 111: 275-297.",
          "Caetano DS, Machado G. 2013. The ecological tale of Gonyleptidae (Arachnida, Opiliones) evolution: phylogeny of a Neotropical lineage of armoured harvestmen using ecological, behavioural and chemical characters. Cladistics 29: 589-609.",
          "Derkarabetian S, Starrett J, Tsurusaki N, Ubick D, Castillo S, Hedin M. 2018. A stable phylogenomic classification of Travunioidea (Arachnida, Opiliones, Laniatores) based on sequence capture of ultraconserved elements. ZooKeys 760: 1-36.",
          "Dumpert K. 1978. Spider odor receptor: Electrophysiological proof. Experientia 34: 754-756.",
          "Ehn R, Tichy H. 1994. Hygro- and thermoreceptive tarsal organ in the spider Cupiennius salei. Journal of Comparative Physiology A: Sensory, Neural, and Behavioral Physiology 174: 345-350.",
          "Faith DP, Cranston OS. 1991. Could a cladogram this short have arisen by chance alone? On permutation tests for cladistic structure. Cladistics 7: 1-28.",
          "Fernandez R, Sharma P, Tourinho AL, Giribet G. 2017. The Opiliones tree of life: shedding light on harvestmen relationships through transcriptomics. Proceedings of the Royal Society B: Biological Sciences 284: 20162340.",
          "Foelix RF. 1985. Mechano- and chemoreceptive sensilla. In: Barth FG, ed. Neurobiology of arachnids. Berlin, Heidelberg: Springer-Verlag, 118-134.",
          "Foelix RF, Axtell RC. 1972. Ultrastructure of Haller's organ in the tick Amblyomma americanum (L.). Zeitschrift fur Zellforschung und mikroskopische Anatomie (Vienna, Austria: 1948) 124: 275-292.",
          "Foelix RF, Chu-Wang IW. 1973. The morphology of spider sensilla. II. Chemoreceptors. Tissue & Cell 5: 461-478.",
          "Foelix RF, Schabronath J. 1983. The fine structure of scorpion sensory organs. I. Tarsal sensilla. Bulletin of the British Arachnological Society 6: 53-67.",
          "Foelix RF, Chu-Wang IW, Beck L. 1975. Fine structure of tarsal sensory organs in the whip spider Admetus pumilio (Amblypygi, Arachnida). Tissue & Cell 7: 331-346.",
          "Gainett G, Sharma PP, Pinto-da-Rocha R, Giribet G, Willemart RH. 2014. Walk it off: predictive power of appendicular characters toward inference of higher-level relationships in Laniatores (Arachnida: Opiliones). Cladistics 30: 120-138.",
          "Gainett G, Michalik P, Muller CH, Giribet G, Talarico G, Willemart RH. 2017a. Ultrastructure of chemoreceptive tarsal sensilla in an armored harvestman and evidence of olfaction across Laniatores (Arachnida, Opiliones). Arthropod Structure & Development 46: 178-195.",
          "Gainett G, Michalik P, Muller CHG, Giribet G, Talarico G, Willemart RH. 2017b. Putative thermo-/hygroreceptive tarsal sensilla on the sensory legs of an armored harvestman (Arachnida, Opiliones). Zoologischer Anzeiger - A Journal of Comparative Zoology 270: 81-97.",
          "Gainett G, Sharma PP, Giribet G, Willemart RH. 2018. The sensory equipment of a sandokanid: an extreme case of tarsal reduction in harvestmen (Arachnida, Opiliones, Laniatores). Journal of Morphology 279: 1206-1223.",
          "Garwood RJ, Sharma PP, Dunlop JA, Giribet G. 2014. A Paleozoic stem group to mite harvestmen revealed through integration of phylogenetics and development. Current Biology 24: 1017-1023.",
          "Giribet G, Sharma PP. 2015. Evolutionary biology of harvestmen (Arachnida, Opiliones). Annual Review of Entomology 60: 157-175.",
          "Giribet G, Vogt L, Gonzalez AP, Sharma P, Kury AB. 2010. A multilocus approach to harvestman (Arachnida: Opiliones) phylogeny with emphasis on biogeography and the systematics of Laniatores. Cladistics 26: 408-437.",
          "Giribet G, Sharma PP, Benavides LR, Boyer SL, Clouse RM, Bivort BLDE, Dimitrov D, Kawauchi GY, Murienne J, Schwendinger PJ. 2012. Evolutionary and biogeographical history of an ancient and global group of arachnids (Arachnida: Opiliones: Cyphophthalmi) with a new taxonomic arrangement. Biological Journal of the Linnean Society 105: 92-130.",
          "Hedin M, Starrett J, Akhter S, Schonhofer AL, Shultz JW. 2012. Phylogenomic resolution of Paleozoic divergences in harvestmen (Arachnida, Opiliones) via analysis of nextgeneration transcriptome data. PLoS ONE 7: e42888.",
          "Hess E, Loftus R. 1984. Warm and cold receptors of two sensilla on the foreleg tarsi of the tropical bont tick Amblyomma variegatum. Journal of Comparative Physiology A: Sensory, Neural, and Behavioral Physiology 155: 187-195.",
          "Hess E, Vlimant M. 1983. The tarsal sensory system of Amblyomma variegatum Fabricius ( Ixodidae, Metastriata). II. No pore sensilla. Revue Suisse de Zoologie 90: 157-167.",
          "Igelmund P. 1987. Morphology, sense organs, and regeneration of the forelegs (whips) of the whip spider Heterophrynus elaphus (Arachnida, Amblypygi). Journal of Morphology 193: 75-89.",
          "Juberthie C. 1979. Un Cyphophthalme nouveau d'une grotte de Nouvelle-Caledonie: Troglosiro aelleni n. gen., n. sp. (Opilion Sironinae). Revue Suisse de Zoologie 86: 221-231.",
          "Juberthie C. 1988. Un nouvel opilion cyphophthalme aveugle d'Australie: Austropurcellia gen. nov., scoparia n.sp. Memoires de Biospeologie 15: 133-140.",
          "Juberthie C. 2000. A new blind Cyphophthalmi (Opiliones) from Queensland (Australia). Memoires de Biospeologie 27: 149-154.",
          "Karanovic T, Kim K. 2014. Suitability of cuticular pores and sensilla for harpacticoid copepod species delineation and phylogenetic reconstruction. Arthropod Structure and Development 43: 615-658.",
          "Kury AB. 1993. Analise filogenetica de Gonyleptoidea (Arachnida, Opiliones, Laniatores). Unpublished PhD Thesis, Sao Paulo: Universidade de Sao Paulo.",
          "Kury AB. 2013. Order Opiliones Sundevall, 1833. Zootaxa 3703: 27-33.",
          "Kury AB. 2014. Why does the Tricommatinae position bounce so much within Laniatores? A cladistic analysis, with description of a new family of Gonyleptoidea (Opiliones, Laniatores). Zoological Journal of the Linnean Society 172: 1-48.",
          "Kury AB, Villarreal MO. 2015. The prickly blade mapped: establishing homologies and a chaetotaxy for macrosetae of penis ventral plate in Gonyleptoidea (Arachnida, Opiliones, Laniatores). Zoological Journal of the Linnean Society 174: 1-46.",
          "Maddison WP, Maddison DR. 2011. Mesquite: a modular system for evolutionary analysis. Version 2.75. Available at: http:// mesquiteproject.org. Accessed on August 2016.",
          "Murphree CS. 1988. Morphology of the dorsal integument of ten opilionid species (Arachnida, Opiliones). Journal of Arachnology 16: 237-252.",
          "Pinto-da-Rocha R, Giribet G. 2007. Taxonomy. In: Pinto-da-Rocha R, Machado G, Giribet G, eds. Harvestmen: the biology of Opiliones. Cambridge: Harvard University Press, 88-246.",
          "Pinto-da-Rocha R , Bragagnolo C, Marques FPL, Antunes Junior M. 2014. Phylogeny of harvestmen family Gonyleptidae inferred from a multilocus approach (Arachnida: Opiliones). Cladistics 30: 519-539.",
          "Platnick NI , Abrahim N , Alvarez-Padilla F , Andriamalala D, Baehr BC, Baert L, Bonaldo AB, Brescovit AD, Chousou-Polydouri N, Duperre N, Eichenberger B , Fannes W , Gaublomme E , Gillespie RG, Grismado CJ, Griswold CE, Harvey MS, Henrard A, Hormiga G, Izquierdo MA, Jocque R, Kranz-Baltensperger Y, Kropf C, Ott R, Ramirez MJ, Raven RJ, Rheims CA , Ruiz GRS, Santos AJ, Saucedo A, Sierwald P, Szuts T, Ubick D, Wang XP. 2012. Tarsal organ morphology and the phylogeny of goblin spiders (Araneae, Oonopidae), with notes on basal genera. American Museum Novitates 3736: 1-52.",
          "Rodriguez AL, Townsend VR. 2015. Survey of cuticular structures on leg IV of cosmetid harvestmen (Opiliones: Laniatores: Gonyleptoidea). Journal of Arachnology 43: 194-206.",
          "Rodriguez AL, Townsend VR, Johnson MB, White TB. 2014a. Interspecific variation in the microanatomy of cosmetid harvestmen (Arachnida, Opiliones, Laniatores). Journal of Morphology 20: 1-20.",
          "Rodriguez AL, Townsend VR, Proud DN. 2014b. Comparative study of the microanatomy of four species of harvestmen (Opiliones, Eupnoi). Annals of the Entomological Society of America 107: 496-509.",
          "Santer RD, Hebets EA. 2008. Agonistic signals received by an arthropod filiform hair allude to the prevalence of nearfield sound communication. Proceedings of the Royal Society B: Biological Sciences 275: 363-368.",
          "Schwendinger PJ. 2007. Oncopodidae Thorell, 1876. In: Pinto-da-Rocha R, Machado G, Giribet G, eds. Harvestmen: the biology of Opiliones. Cambridge: Harvard University Press, 211-214.",
          "Sharma P, Giribet G. 2009. Sandokanid phylogeny based on eight molecular markers -the evolution of a southeast Asian endemic family of Laniatores (Arachnida, Opiliones). Molecular Phylogenetics and Evolution 52: 432-447.",
          "Sharma PP, Giribet G. 2011. The evolutionary and biogeographic history of the armoured harvestmen - Laniatores phylogeny based on ten molecular markers, with the description of two new families of Opiliones (Arachnida). Invertebrate Systematics 25: 106-142.",
          "Sharma PP, Giribet G. 2014. A revised dated phylogeny of the arachnid order Opiliones. Frontiers in Genetics 5: 255.",
          "Strong EE, Lipscomb D. 1999. Character coding and inapplicable data. Cladistics 15: 363-371.",
          "Talarico G, Palacios-Vargas JG, Silva MF, Alberti G. 2005. First ultrastructural observations on the tarsal pore organ of Pseudocellus pearsei and P. boneti (Arachnida, Ricinulei). Journal of Arachnology 33: 604-612.",
          "Tichy H, Barth FG. 1992. Fine structure of olfactory sensilla in myriapods and arachnids. Microscopy Research and Technique 22: 372-391.",
          "Tichy H, Loftus R. 1996. Hygroreceptors in insects and a spider: humidity transduction models. Naturwissenschaften 220: 255-263.",
          "Tomasiewicz B, Framenau VW. 2005. Larval chaetotaxy in wolf spiders (Araneae, Lycosidae): systematic insights at the subfamilial level. Journal of Arachnology 33: 415-425.",
          "Townsend VR, Bertram MS, Milne MA. 2015. Variation in ovipositor morphology among laniatorean harvestmen (Arachnida: Opiliones). Zoomorphology 134: 487-497.",
          "Wijnhoven H. 2013. Sensory structures and sexual dimorphism in the harvestman Dicranopalpus ramosus (Arachnida: Opiliones). Arachnologische Mitteilungen 46: 27-46.",
          "Willemart RH, Giribet G. 2010. A scanning electron microscopic survey of the cuticle in Cyphophthalmi (Arachnida, Opiliones) with the description of novel sensory and glandular structures. Zoomorphology 129: 175-183.",
          "Willemart RH, Gnaspini P. 2003. Comparative density of hair sensilla on the legs of cavernicolous and epigean harvestmen (Arachnida: Opiliones). Zoologischer Anzeiger - A Journal of Comparative Zoology 242: 353-365.",
          "Willemart RH, Chelini MC, de Andrade R, Gnaspini P. 2007. An ethological approach to a SEM survey on sensory structures and tegumental gland openings of two Neotropical harvestmen (Arachnida, Opiliones, Gonyleptidae). Italian Journal of Zoology 74: 39-54.",
          "Willemart RH, Farine JP, Gnaspini P. 2009. Sensory biology of Phalangida harvestmen (Arachnida, Opiliones): a review, with new morphological data on 18 species. Acta Zoologica 90: 209-227.",
          "Wolff JO, Schonhofer AL, Martens J, Wijnhoven H, Taylor CK, Gorb SN. 2016. The evolution of pedipalps and glandular hairs as predatory devices in harvestmen (Arachnida, Opiliones). Zoological Journal of the Linnean Society 177: 558-601."
        ],
        "resource_type": {
          "title": "Journal article",
          "type": "publication",
          "subtype": "article"
        },
        "journal": {
          "issue": "1",
          "pages": "143-165",
          "title": "Zoological Journal of the Linnean Society",
          "volume": "187"
        },
        "alternate_identifiers": [
          {
            "identifier": "urn:lsid:plazi.org:pub:FF9BAD4F5E56FFFED112FFEBFFD9BC5C"
          },
          {
            "identifier": "http://publication.plazi.org/id/FF9BAD4F5E56FFFED112FFEBFFD9BC5C"
          }
        ],
        "communities": [
          {
            "id": "biosyslit"
          }
        ],
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "14828913"
              }
            }
          ]
        }
      },
      "title": "Evolution of a sensory cluster on the legs of Opiliones (Arachnida) informs multi-level phylogenetic relationships",
      "links": {
        "self": "https://zenodo.org/api/records/14828914",
        "self_html": "https://zenodo.org/records/14828914",
        "doi": "https://doi.org/10.1093/zoolinnean/zlz016",
        "self_doi": "https://doi.org/10.1093/zoolinnean/zlz016",
        "self_doi_html": "https://zenodo.org/doi/10.1093/zoolinnean/zlz016",
        "parent": "https://zenodo.org/api/records/14828913",
        "parent_html": "https://zenodo.org/records/14828913",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:14828914/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:14828914/sequence/default",
        "files": "https://zenodo.org/api/records/14828914/files",
        "media_files": "https://zenodo.org/api/records/14828914/media-files",
        "archive": "https://zenodo.org/api/records/14828914/files-archive",
        "archive_media": "https://zenodo.org/api/records/14828914/media-files-archive",
        "latest": "https://zenodo.org/api/records/14828914/versions/latest",
        "latest_html": "https://zenodo.org/records/14828914/latest",
        "versions": "https://zenodo.org/api/records/14828914/versions",
        "draft": "https://zenodo.org/api/records/14828914/draft",
        "reserve_doi": "https://zenodo.org/api/records/14828914/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/14828914/access/links",
        "access_grants": "https://zenodo.org/api/records/14828914/access/grants",
        "access_users": "https://zenodo.org/api/records/14828914/access/users",
        "access_request": "https://zenodo.org/api/records/14828914/access/request",
        "access": "https://zenodo.org/api/records/14828914/access",
        "communities": "https://zenodo.org/api/records/14828914/communities",
        "communities-suggestions": "https://zenodo.org/api/records/14828914/communities-suggestions",
        "requests": "https://zenodo.org/api/records/14828914/requests"
      },
      "updated": "2025-02-07T00:37:23.896827+00:00",
      "recid": "14828914",
      "revision": 7,
      "files": [],
      "swh": {},
      "owners": [
        {
          "id": "1161"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 0,
        "unique_downloads": 0,
        "views": 2,
        "unique_views": 2,
        "version_downloads": 0,
        "version_unique_downloads": 0,
        "version_unique_views": 2,
        "version_views": 2
      },
      "state": "done",
      "submitted": true
    }
  ]
}